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Abstract 
Repo-Man is a chromatin-associated PP1 targeting subunit that coordinates 
chromosome re-organisation and nuclear envelope reassembly during mitotic exit. At the 
onset of mitosis, Repo-Man association with the chromosomes is very dynamic; at anaphase, 
Repo-Man targets to the chromatin in a stable manner and recruits PP1 to de-phosphorylate 
histone H3 at Thr3, Ser10 and Ser28. Previous studies have suggested that CDK1 and 
AuroraB are the kinases responsible for the inactivation of the complex and for its dispersal 
at the onset of mitosis respectively.  We have previously shown that the binding of Repo-
Man to PP1 is decreased in mitosis and we have identified a region adjacent to the RVTF 
motif that contains multiple mitotic phosphosites (RepoSLIM). This region is conserved only 
in another PP1 targeting subunit: Ki-67.  In order to understand the importance of this region 
for the complex formation and stability, we have conducted mutational analyses on several 
residues, and addressed their contribution towards Repo-Man chromosome targeting and 
PP1 binding in vivo.   We have identified new sites in Repo-Man that, when phosphorylated, 
contribute to the weakening of the binding between Repo-Man and PP1. Interestingly, our 
results also indicate that several kinases are involved in the mitotic regulation of the 
complex. We have also identified Lamin A/C as a Repo-Man substrate and introduced a new 
model for Lamin A/C regulation at interphase. Furthermore, we identified Repo-Man as a 
marker of malignancy in tripe egative breast cancer, which controls cell movement and 
levels of important oncogenic markers Aurora A and C-Myc, and propose Repo-Man/PP1 
complex as a therapeutic target for the treatment of triple negative breast cancer through 
the newly identified RepoSLIM.   
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1.1 Cell Cycle 
The term cell cycle summarizes the life of a cell and the events that take place during 
that time. It is defined as a cycle because a cell goes through the exact same process over 
and over again resulting in dividing and proliferating until the cell dies or exit it to become a 
differentiated or quiescent cell. The cell cycle is separated into several phases. These are G1, 
S, G2 phases, which are also collectively called the interphase, and M phase (Figure 1.1). 
These phases represent the growth and division of the cell. At interphase the cell grows, 
produces energy, handles transportations and other duties as well as transcription of 
proteins. The first phase within interphase is the G1 (Gap1), where the cell activity is at its 
highest as the majority of the cell growth happens at this stage. The second phase is the S 
phase, which stands for synthesis, where the DNA replication occurs. At the third phase, G2 
(Gap 2), with the duplicated DNA the cell continues to grow and synthesise proteins to 
prepare for the M phase (Cooper, 2000).  
M phase stands for mitosis and this is the stage where the cell divides. In mitosis all 
the genetic information is equally distributed between the two daughter cells. After mitosis, 
the two new daughter cells start their new cycle. M phase itself has several stages:   
prophase, where the replicated chromatin starts to condense and the nuclear lamina is dis-
assembled; pro-metaphase, where the chromosomes are condensed and ready to  form the 
metaphase plate, the mitotic spindle is formed; metaphase, where the chromosomes are 
aligned on the metaphase plate and fibres of the mitotic spindles are attached to each single 
chromatid at the kinetochore; anaphase, where the sister chromatids separate and move 
towards opposite spindle poles; telophase, where sister chromatids reach the poles and, 
nuclear lamina starts to reform and the cleavage furrow ingresses in the middle of the cell; 
4 
 
cytokinesis, where the division of the cytoplasm occurs and the daughter cells separate from 
each other completely (O’Connor, 2008).  
Sometimes cells enter a phase called G0. This is the phase where the cell does not 
grow or proliferate and is called the resting phase or quiescence. This is usually due to lack of 
nutrients, oxygen or other environmental factors; this status is usually reversible and, when 
the necessary conditions are provided the cell can re-enter the cycle again. When the cell 
accumulates too much DNA damage or somehow loses its function it can enters a similar 
stage called senescence, where the cell does not proliferate and is committed to die 
(Sharpless and Sherr, 2015).   
The cell cycle is a highly regulated and controlled process with monitoring stages to 
ensure that some events do not occur until the previous ones are successfully completed: 
these are called check points. There are many important events that need to be controlled 
within the cell cycle including DNA replication and mitosis. After division, the very first 
checkpoint is when the cell goes from G1 to S phase. This is when the cell decides if it is 
ready to commit to the DNA replication. In the presence of appropriate growth factors and 
nutrients the cell decides that it needs to divide in order to allow further growth. Another 
important checkpoint is at the G2, when the cell needs to make sure that the whole genome 
is replicated without any errors. This also prevents the cell from going through mitosis with a 
semi-replicated DNA. At this stage, any DNA damage is also detected and the cell repairs 
these errors before mitosis. If, in any way the damage is not repairable, the cell may go 
through apoptosis, a programmed cell death, in order not to carry the same error to the 
subsequent cell cycle (Figure 1.1).  
  5 
 After a successful DNA replication the cell prepares for mitosis at G2. During mitosis 
there is a very important checkpoint where the cell needs to make sure that each sister 
chromatid is successfully attached to the spindle fibres coming from opposite poles to 
ensure and equal distribution of the genetic information between the two daughter cells. If 
this attachment is not successful, it may result in lagging chromosomes and different 
chromosome numbers in the two daughter cells (explained in the SAC section). When all of 
these checkpoints are satisfied, the cell successfully divides and continues to grow (Cooper, 
2000). 
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Figure 1.1: Cell cycle and checkpoints explained. Diagram showing the cell cycle stages G1, 
S, G2 and M as well as stages of mitosis and checkpoints. G0, quiescence/senescence stage is 
also shown, where the cell does not divide and lives on minimum metabolism. There are 
three major checkpoints during cell cycle (shown in red), at G1, G2-S and M. These are 
designed to make sure each stage is completed without any errors. (Image taken from 
McGraw-Hill, Chapter 8 Cell Division and Reproduction.) 
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1.1.1 Role of kinases and phosphatases 
Kinases and phosphatases are catalytic proteins that transfer phosphate groups to 
and from their substrates. A kinase transfers a phosphate group from ATP or GTP to its 
substrate, whereas a phosphatase opposes this activity by catalysing the removal of a 
phosphate group from its substrates. Phosphorylation and de-phosphorylation are without a 
doubt the most predominant post-translational modifications that regulate structures and 
functions of a wide range of proteins by activating or inactivating their substrates (Ubersax 
and Ferrel, 2007). Phosphorylation acts as a molecular switch, affecting important cellular 
processes from cell division to cell metabolism and cell death. When a protein is 
phosphorylated, this may result in conformational changes allowing or blocking its 
interactions with other proteins (Holt et al., 2009). Phosphorylation can also affect protein-
protein interactions by blocking or releasing the interactive or active surfaces of target 
proteins (Serber and Ferrel, 2007). The functions of both kinases and phosphatases are 
mediated by their substrate proteins and understanding how they recognise their targets is 
important to have a better understanding their role in the cell cycle.  
Kinases either recognise their target proteins phosphorylation sequence with their 
active site or use a docking motif that may be on the kinase or on the target substrate (Turk, 
2008). These interactions allow kinases to bind to their substrates with excellent specificity. 
Similarly, phosphatases also recognise their substrates via an interaction or docking motif on 
their substrates. These motifs are usually located at a distance from the active site of the 
kinase or phosphatase, since the active site is where the phosphorylation or de-
phosphorylation is achieved and it should not be blocked unless the kinase or the 
phosphatase activity is being inhibited willingly (Roy and Cyert, 2009). Some phosphatases 
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like protein phosphatase 1 (PP1) bind to proteins that target them to their actual substrates. 
These are called regulatory or targeting subunits and they can either increase the specificity 
of PP1 or direct it to de-phosphorylate a different substrate (Bollen et al., 2010).  
  When a cell proceeds from one phase to another, it needs to make sure that this 
transition is irreversible. This is achieved by activating specific kinases to phosphorylate 
specific targets for that stage of the cell cycle (Novak et al., 2010). What makes these 
transitions irreversible, is the degradation of certain proteins that can reverse these 
reactions at this stage, so that the necessary phosphorylation and de-phosphorylation 
processes remain. Cyclins are the best example for this type of degradation. Along with 
cyclin dependent kinases (CDKs) are the cell cycle regulators that are activated at different 
stages of the cell cycle. CDKs are activated only when they are bound to cyclins, when they 
phosphorylate their target proteins. At each stage a different cyclin is activated so a different 
pair of cyclin/CDK is responsible for the progression of each stage. CDKs 1, 2, 4 and 6 along 
with cyclins A, B, D and E are involved in this process (Bonelli et al., 2014). Cyclin/CDK activity 
starts a phosphorylation cascade that leads to the activation of necessary transcription 
factors and therefore transcription of targeted genes. For example, the CDK4-CyclinD 
complex phosphorylates the retinoblastoma (Rb) protein along with CDK2-Cyclin E in G1, 
which then activates the transcription factors necessary for the S phase (Dyson, 1998; 
Hatakeyama and Weinberg, 1995). Similarly, CDK1-Cyclin B phosphorylates a wide range of 
proteins at the beginning of mitosis to make sure the process is completed without any 
problems (Errico et al., 2010); these multiple phosphorylations are then removed by 
different phosphatases at the end of mitosis so that the cell can go back to its essential 
functions (Nilsson and Hoffmann, 2000; Domingo-Sananes et al., 2011; Swaffer et al., 2016). 
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Other kinase cascades activate transcription factors and lead to cell differentiation, 
proliferation or apoptosis. Mitogen-activated protein- kinase (MAPK), phosphoinositide 3-
kinase (PI3K), Akt, mammalian target of rapamycin (mTOR) as well as protein kinase A (PKA) 
and protein kinase C (PKC) pathways are involved in the regulation of fundamental cellular 
processes. These pathways crosstalk between each other and they importance for cell 
survival is highlighted by the fact their mis-regulation is part of important oncogenic 
pathways; overexpression of some of these kinases can lead to an overgrown population of 
cells that could potentially turn into cancer cells, whereas the opposing phosphatases are 
considered as tumour suppressors because they can de-phosphorylate these oncogenic 
targets (Bononi et al., 2011).  
The opposing activity between kinases and phosphatases ensures that each stage of 
the cell cycle is highly regulated and controlled so that the each cell cycle is properly 
completed and a new one can re-started without any problems: this is particularly important 
when the cells exit mitosis and enter G1.  
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1.1.2 From mitosis to G1 
 Mitosis is a complex, well-structured and highly organised process that allows a cell 
to divide and form two genetically identical daughter cells.  It includes a number of vital 
steps like chromosome condensation, nuclear envelope disassembly, chromosome 
segregation, reformation of the nuclear envelope and chromosome de-condensation. All 
these events are controlled by activation and inactivation of certain proteins, which is 
achieved by phosphorylation and de-phosphorylation processes throughout mitosis. 
Resetting the cell cycle and resuming all the functions in the cell after mitosis 
depends on the reversal of the events mentioned above and re-establishing protein-protein 
interactions as well as epigenetic changes. These should happen in the correct order and in a 
regulated manner. The preparation for the start of the next cycle starts towards the end of 
mitosis, and is called the mitotic exit. Mitotic exit begins with the inactivation of mitotic 
kinases and activation of relevant phosphatases for the reversal of the phosphorylations. 
These de-phosphorylations occur in many components of the cell including the nuclear 
lamina for the re-formation of the nuclear envelope, histone proteins for the re-packaging of 
the DNA and several transcription factors to trigger cell growth (de Castro et al. 2015).   
It is well-known that entry into mitosis depends on the activation of CDK1-Cyclin B 
complex, which initiates phosphorylation of a broad range of proteins. The activation of this 
complex is achieved by the phosphatase Cdc25 through de-phosphorylation of its inhibitory 
residues, Thr14 and Thr15 (Draetta et al., 1988; Gould et al., 1989; Krek et al., 
1991).Phosphorylation by CDK1-Cyclin B has an inhibitory effect on its substrates, making 
sure that these substrates do not interfere with the progression of mitosis.
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The first sign of mitotic exit is the inactivation of CDK1-Cyclin B by degradation of 
Cyclin B. This is achieved by the proteasome after being marked by the ubiquitin ligase 
anaphase promoting complex (APC), and results in chromosome segregation as well as 
CDK1-Cyclin B inactivation (Glotzer et al., 1991). When CDK1-Cyclin B is inactivated, the de-
phosphorylation of its substrates begins. Although the inactivation of CDK1-Cyclin B is crucial 
for mitotic exit, the activity of phosphatases is equally important to prepare the cell for a 
functional G1 nucleus (Sullivan and Morgan, 2007). The best example of this is the 
identification of PP2A as an essential mitotic exit phosphatase. Activity of PP2A-B55δ was 
reported to be essential for mitotic entry and exit in Xenopus egg extracts (Mochida and 
Hunt, 2012; Mochida et al., 2009) and furthermore, this activity was found to be regulated 
by the Greatwall kinase through the activation of PP2A-B55δ inhibitors (Mochida et al., 
2010; Gharbi-Ayachi et al., 2010; Lorca and Castro, 2012). 
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1.2 Ser/Thr phosphatases 
The Ser/Thr phosphatase family is one of the two major families of phosphatases along 
with protein tyrosine phosphatases (PTPs). Both families are named according to the type of 
amino acid they de-phosphorylate. It has been well established that Ser/Thr phosphorylation 
and de-phosphorylation regulates more important processes during cell division than PTPs 
(Barr et al., 2011).  They influence many pathways involving in cell proliferation, apoptosis, 
embryonic development, cell motility and cell differentiation (Janssens and Goris, 2001; 
Barford, 1996). The effect of Ser/Thr phosphatases on multiple important processes was 
proven by their inhibition using okadaic acid, an algal toxic specific for Ser/Thr phosphatases, 
which triggered many changes in mitosis like chromatin condensation and re-arrangement of 
organelles (Lucocq et al., 1991; Yamashita et al., 1990). This also indicates that inhibiting 
Ser/Thr phosphatase activity is as important as activating protein kinases at mitotic entry, 
and mitotic exit requires the reversal of these activities as mentioned before.  
The two most abundant Ser/Thr phosphatases in most of the cell types, protein 
phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), both form holoenzyme complexes 
with their associated regulatory or scaffolding subunits. These holoenzymes are then 
targeted to the substrate for de–phosphorylation process to occur. This regulatory system is 
designed to increase target specificity and to prevent random binding of PP1 or PP2A to any 
other protein at any given time. In this section, molecular structures of both PP1 and PP2A 
will be explained in detail.  
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1.2.1 Structure and function of PP1  
PP1 is a 38.5 kDa protein that is coded by three different genes giving rise to four 
different isoforms: PP1α, PP1β/δ, PP1γ1/γ2. There is 85-93% similarities between these 
isoforms and the majority of differences are at the N and C terminal ends. All PP1 isoforms 
are ubiquitous except for PP1γ2, which is restricted to the testis. The interaction and activity 
of PP1 is strictly regulated by its interaction with more than 200 targeting proteins (Bollen et 
al., 2010). These targeting subunits localise PP1 to certain regions of the cell to de-
phosphorylate its targets. For example, when PP1 binds to Repo-Man it is recruited to 
chromatin at anaphase onset to de-phosphorylate histone H3 (Vagnarelli et al., 2006; 
Trinkle-Mulachy et al., 2006); when PP1 binds to PNUTS it stimulates chromosome de-
condensation when the cells re-enter interphase (Landsverk et al., 2005) or when it binds to 
AKAP149 it helps the formation of nuclear lamina (Steen et al., 2000). The plethora of 
subunits also include some inhibitors like the inhibitor 2 (I-2) and DARPP-32, which bind to 
and block the active site of PP1.  
The active site, also called the catalytic site, is at the intersection of the substrate 
binding hydrophobic, acidic and C-terminal grooves (Figure 1.2, A and B) and it contains two 
metal ions (Mn+2) (Dancheck et al., 2011; Kelker et al., 2009). The interaction with the 
targeting subunits occurs through a motif called the RVxF (x stands for any amino acid except 
for Phe, Ile, Met, Tyr, Asp or Pro), which is common to almost all targeting subunits and 
inhibitors of PP1 (Wakula et al., 2003; Meiselbach et al., 2006; Bollen et al., 2010).  
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The interaction through the RVxF motif is necessary but it does not affect the 
enzymatic activity of PP1, since it is away from the active site. There are also other docking 
motifs like SILK and MyPhoNE that contribute to the regulation of PP1 substrate specificity 
(Hendrickx et al., 2009).  
As a phosphatase that interacts with a large number of targeting subunits and 
substrates, the remaining question about PP1 is the molecular mechanism of holoenzyme 
and substrate recognition. There are only a few well-studied examples of PP1 holoenzymes 
up to date. These are: PP1/spinophilin in neurons (Ragusa et al., 2010); PP1/MYPT1 in 
muscle (Terrak et al., 2004; Yamashiro et al., 2008); PP1/inhibitor-2 (Hurley et al., 2007; 
Marsh et al., 2010); PP1/neurabin (Ragusa et al., 2010). In addition, toxin bound and 
inhibited PP1 crystal structures have also been obtained. These include PP1 bound to 
okadaic acid (Maynes et al., 2001), caluculin A (Kita et al., 2002) and nodularin R (Kelker et 
al., 2009). These crystal structure studies have also revealed that the majority of PP1 binding 
subunits are highly disordered when they are not bound to PP1. They do not have a well-
defined three dimensional structure and these are defined as intrinsically disordered or 
unstructured proteins (IDPs/IUPs) (Hurley at el., 2007). Being intrinsically disordered gives 
them some sort of flexibility that enables them to form unique interactions with PP1 (Ragusa 
et al., 2010; Terrak et al., 2004) and they can adopt different protein surfaces binding motifs. 
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Figure 1.2: Structure of PP1. A. Crystallized PP1 catalytic subunit (PP1c), showing the 
active/catalytic site with two Mn+2 ions (in pink) and the binding of a variable and 
exchangeable regulatory or targeting subunit (in blue). B. Crystallized PP1, showing the 
active site at the intersection of three grooves. C, H and A represent C-terminal, hydrophobic 
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    PP1 substrate-specificity depends highly on the targeting subunit as the targeting 
subunit may block or extend certain grooves on PP1, which might then allow PP1 to interact 
with a limited number of substrates via the remaining grooves. An example for this type of 
interaction is Spinophilin, which blocks the C-terminal groove of PP1, restricting its 
interaction to the substrates that can interact with the acidic and hydrophobic grooves 
(Ragusa et al., 2010). Similarly, MYPT1 extends the acidic groove, creating more space to 
bind for the substrate, which then makes the acidic groove more preferable than the others 
(Terrak et al., 2004).    
Another important question is: How is the selectivity achieved between PP1 and its 
interacting proteins? The selectivity is achieved through the regulation of PP1 interacting 
proteins. PP1 activity depends highly on the interacting proteins, as it is never found on its 
own in the cell. The regulation might happen by the phosphorylation of the interacting 
protein, which changes the binding affinity, or in some cases, the activation and expression 
of the binding protein is cell type specific (Moorhead et al., 2007; Virshup and Shenolikar, 
2009). Even with phosphorylation, it is still hard for the cell to control the pool of PP1 
interacting proteins. It was shown that to solve this problem, the concentration of PP1 
binding proteins in the cell is regulated by proteolysis: this is true for GADD34 and R5/PTG 
(Brush et al., 2003; Vernia et al., 2009). Overall, the concentration and affinities of PP1 
interacting proteins determine which PP1 holoenzymes are being formed in the cell.  
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1.2.2 Structure and function of PP2A 
PP2A is a heterodimer formed by a 36 kDa catalytic subunit (C subunit), a 65 kDa 
structural subunit (A subunit) and a variable regulatory subunit (B subunit), which can vary in 
size (55 to 130 kDa) (Figure 1.3, A and B). The A and C subunits form the catalytic complex 
which then binds to different variable B subunits (B55/B56 and PR72/PR130). PP2A 
holoenzymes are vastly diverse due to several isoforms of each subunit and different 
combinations of these isoforms (Bononi et al., 2011). The regulatory B subunits play a crucial 
role in PP2A activity and they achieve this by regulating substrate selectivity. Some of the B 
subunits target PP2A to multiple places like the microtubules, nucleus or mitochondria, 
whereas some B subunits have a more restricted number of targets inside the nucleus (Shi, 
2009; Janssens et al., 2005; Forester et al., 2007). This different localisation patterns are 
caused by different signals carried by different B isoforms.  
For example, in the beta isoform of B56 (B56β) only a nuclear export signal is present 
whereas in alpha, and epsilon isoforms (B56α and B56ε) both nuclear export and nuclear 
localisation signals are present. As a consequence, B56 proteins that have nuclear export 
signals are shuttled to the cytoplasm after mitosis. The different localisation of B56 subunits 
therefore allow PP2A to target a wide range of proteins distributed not only in the nucleus 
but also in the cytoplasm (Flegg et al., 2010; Jin et al., 2009; Riedel et al., 2006). As clearly 
understood from the given examples, most PP2A regulatory subunits do not have a targeting 
motifs but their presence help PP2A compartmentalization within the cell.  
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Figure 1.3: Structure of PP2A. A. Crystal structure of PP2A, showing the catalytic C subunit 
with two metal ions (in pink) A subunit and variable B subunit (in blue) (c represents catalytic 
subunit) (Image taken from Peti et al., 2012). B. Secondary structure of PP2A, showing 
different isoforms of each subunit. (Image taken from Sangodkar et al., 2015).  
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PP2A influences and controls many important cellular processes in the cell. These 
include glycolysis and lipid metabolism (Tung et al., 1985) as well as cell proliferation, DNA 
replication, cytoskeleton dynamics signal transduction, cell mobility and transcription and 
translation (Alberts et al., 1993; Glenn and Eckhart, 1993; Ronne et al., 1991; Schonthal, 
2001). Moreover, PP2A is involved in intrinsic apoptosis pathway by de-phosphorylating Bcl-
2 and creating an anti-proliferative signal, therefore it is considered as a tumour suppressor 
and targeted for the treatment of several cancers (Ruvolo et al., 2002).  
As mentioned before, regulation of PP2A mostly depends on the diversity of its 
subunits. But, apart from subunit diversity, PP2A is also regulated by phosphorylation and 
methylation. The TPDYFL conserved amino acid sequence on PP2A can be phosphorylated 
and methylated at tyrosine (Y) and leucine (L) residues. This effectively decreases PP2A 
activity and prevents its interaction with regulatory subunits (Longin et al., 2007). PP2A is 
also phosphorylated by a kinase capable of performing auto-phosphorylation, which alters 
PP2A efficacy (Guo, H. and Damuni, Z., 1993). Methylation of PP2A is achieved by PP2A-
methyltransferase (PPMT). Addition of a methyl group to L309, enhances the binding affinity 
of the catalytic complex (A and C subunits) for certain regulatory subunits (B-alpha), hence 
provides specificity (Leulliot et al., 2004). From all of the information above, we can conclude 
that both PP1 and PP2A are important phosphatases that regulate essential pathways in the 
cell. Although their regulation or holoenzyme structures are not the same, they work in 
similar ways and they both have a wide range of substrates. From here onwards, I will focus 
specifically on phosphatases at mitotic exit and explain mitotic exit proteins as well as the 
proteins of relevance for this thesis. 
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1.3 Important players of mitotic exit 
1.3.1 PP1 and PP2A at mitotic exit 
Role of phosphatases in mitotic entry and exit was reported in two papers in the 
early 90s by using the PP1 and PP2A inhibitor Okadaic Acid (OA) on Xenopus egg extracts. In 
both papers PP2A is suggested to de-phosphorylate Cdc25 and maintain it at a low activity 
state, which negatively regulates the cell cycle (Felix M. A. et al., 1990; Clarke P.R., 1993). 
Later on, the importance of PP2A in mitotic exit was further proven by studies performed in 
budding yeast. Wang and Ng reported that PP2A negatively regulates mitotic exit by 
regulating the de-phosphorylation of Tem1, which acts at the very top of the MEN pathway 
(Wang and Ng, 2005), while Queralt and colleagues found a down-regulatory pathway of 
PP2A by separase that initiates mitotic exit by the activation of mitotic exit network (MEN) 
(Queralt et al., 2006).  
The complex structure of PP2A clearly links this phosphatase to the regulation of 
different specific actions by its multiple subunits and isoforms. Unsurprisingly, PP2A-B56δ 
was then reported to be the only member of PP2A-B56 to directly bind to Cdc25C in human 
cells in vivo and negatively regulate it by de-phosphorylating Cdc25C at Thr130 and 
maintaining the binding of 14-3-3 to Cdc25C at interphase (Margolis et al., 2006). Also at M 
phase, the PP2A-B56δ was reported to interact with Cdc25C, which leads to the inactivation 
of the Cdk1-Cyclin B complex and makes PP2A-B56δ and important regulator of mitotic exit 
(Forester et al., 2007). Forester and colleagues proved this further by generating a stable 
knockdown of B56δ in mammalian cells and observed that Cdc25C is hyper-phosphorylated 
and Cyclin B degradation is delayed, resulting in the delays of mitotic exit. The importance of 
PP2A-B56δ was also proven by its depletion from Xenopus egg extracts.  
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It was observed that PP2A-B56δ depleted cells at interphase go into mitosis faster 
and remain in mitosis indefinitely, whereas PP2A-B55δ depletion in mitotic extracts did not 
have an effect on mitotic exit (Mochida et al., 2009). These observations suggest that B56δ 
and B55δ are crucial subunits of PP2A for entry into and exit from mitosis but other 
phosphatases must also be involved in the process and, considering the complex structure of 
PP2A, these subunits cannot be the only regulators. Soon after the discovery of the roles of 
PP2A-B55δ and B56δ another subunit of PP2A was reported to be a key regulator of mitotic 
exit. Using RNAi knockdown and live cell imaging, Schmitz and colleagues screened a 
genome-wide protein phosphatase library to identify mitotic exit proteins and they found 
PP2A-B55α along with importin-β1 as a key factor in mitotic spindle breakdown and nuclear 
envelope reassembly (Schmitz et al., 2010). The dynamics and mathematical model of PP2A 
control over the cell cycle and cell cycle transitions revealed that PP2A controls the 
separation of S phase and mitosis by counteracting Cdk1 activation and activity of mitotic 
kinases (Krasinska et al., 2011).  
It is important that early phosphatase activity and early entry into mitotic exit is 
prevented: this is achieved by the accumulation of phosphorylations. Most of these 
phosphorylations are carried out by Cdk1 to assure correct entry into mitosis but there are 
other kinases as well, which make sure mitotic exit proteins are inactive during this stage 
(Vigneron et al., 2009; Castilho et al., 2009). Greatwall kinase is one of these kinases known 
to act on PP2A and inhibit its activity upon mitotic entry. It was found to phosphorylate two 
other proteins arpp19 and ensa, which associate with and inhibit PP2A at its B55 type 
regulatory subunits (Mochida et al., 2010; Gharbi-Ayachi et al., 2010). A human homologue 
of the Greatwall kinase was identified as a microtubulue-associated-serine/threonine kinase-
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like (MASTL) but how this protein is related to other phosphatases in human cells is not 
completely established (Voets and Wolthuis, 2010; Burgess et al., 2010). In addition, PP1 
activity is also supressed upon mitotic entry both by direct phosphorylation or binding of the 
inhibitor-1. Direct phosphorylation of PP1 is achieved in mammalian cells by Cdk1 and the 
binding of inhibitor-1 depends on its phosphorylation by PKA (Kwon et al., 1997; Dohadwala 
et al., 1994). Inhibition of PP1 is important to protect mitotic phosphosites from early de-
phosphorylation before mitotic exit.  
As mentioned above, PP1 and PP2A are largely inactive at the beginning of mitosis 
but they should be activated at mitotic exit onset to regulate de-phosphorylations and allow 
the cell to finalise mitosis. An important investigation on how these phosphatases are 
activated at mitotic exit was led by Grallert and colleagues in early 2015 and an important 
regulatory cascade was discovered. They report an interaction between PP1 and PP2A-
B55/B56, which leads to a relay of de-phosphorylations, activating both phosphatases 
(Figure 1.4). This process is reported to be essential for chromosome segregation and 
therefore for cell division (Grallert et al., 2015). This study was carried on in fission yeast but 
they report a similar interaction in human cells as well. The discovery of this cascade raised 
new questions about the B55 and B56 subunits of PP2A. Structurally, these subunits have 
hydrophobic cores and their PP1 binding sites are folded in these cores (Shi, 2009). 
Therefore, it seems impossible for these proteins to interact with PP1 without disrupting the 
well-folded domains in the core. One possible explanation, still to be demonstrated, is that 
the proteins possibly change confirmation and expose their PP1 binding sites upon binding 
and activation. There are proteins known to undergo conformational changes (Whisstock 
and Bottomley, 2006) but it is not clear if this is the case in the interaction of PP1 and PP2A.
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Figure 1.4: The PP1-PP2A phosphatase relay at mitosis. At early mitosis PP1 is 
phosphorylated by CDK1. Phosphorylated PP2A-B55 is associated with phosphorylated PP1 
and when CDK1 is inactivated, PP1 activates itself by removing its phosphate group. Active 
PP1 then de-phosphorylates bound PP2A-B55 to activate it. Active PP2A-B55 removes one of 
the phosphate groups on PP2A-B56 and allows it to bind to PP1. This is may be delayed 
because of Plk1 activity which counteracts PP2A-B55 but when Plk1 is inactivated in late 
mitosis PP2-B56 is successfully de-phosphorylated and binds to PP1. PP2A-B56 is then de-
phosphorylated once again by PP1 and released. (As explained in Grallert et al., 2015, image 
taken from Bollen, 2015) 
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1.3.2 Spindle assembly checkpoint (SAC) 
 In eukaryotic cells, the spindle assembly checkpoint (SAC) acts as a control 
mechanism by monitoring chromosome bi-orientation and alignment on the mitotic spindle 
at metaphase. The purpose of this is to detect any unattached or improperly attached 
chromosomes on the metaphase plate. At this stage the cell continues to remain in mitosis 
until the problem is fixed and all the chromosomes are aligned correctly. SAC prevents the 
cell from losing or gaining any of the sister chromatids, therefore inheriting wrong number 
of chromosomes in the daughter cells. This is achieved by a sensory apparatus that monitors 
the chromosome attachment to the mitotic spindle and an effector complex that targets the 
mitotic machinery. Like all other cell cycle mechanisms, SAC is also regulated by reversible 
phosphorylations (Foley and Kapoor, 2013).  
The effector complex of SAC is called the mitotic checkpoint complex (MCC), which 
targets the anaphase-promoting complex (APC) and is activated by the unattached 
kinetochores. The APC is crucial for mitotic exit as it is responsible for ubiquitination of Cyclin 
B and Securin, promoting their destruction. Cyclin B, as mentioned before, keeps its targets 
phosphorylated with CDK1 and a successful mitotic exit requires its inactivation as well as 
de-phosphorylation of all its targets. Securin on the other hand, is a protein that blocks the 
Separase enzyme, which targets cohesin molecules (a complex that holds sister chromatids 
together) and promotes sister chromatid separation. By targeting and inhibiting APC, MCC 
stabilizes Cyclin B and Securin, which effectively prevents mitotic exit (Figure 1.5) (Primorac 
and Musacchio, 2013).   
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Chromosome attachment to microtubules is mediated by the kinetochores. These are 
multi-subunit structures, where the mitotic spindle is attached during cell division to pull the 
sister chromatids apart. They have an inner and outer layer. The inner layer interacts with 
the centromeres of the chromosomes, whereas the outer layer is involved in mitotic spindle 
binding and SAC activation (Fukagawa and Earnshaw, 2014; McKinley and Cheeseman, 
2014). Specifically, the KMN network, formed of kinetochore null protein 1 (KNL1), mis-
segregation 12 (MIS12) complex and the nuclear division cycle 80 (NDC80) complex, is 
responsible for kinetochore attachment to the spindle and also for MCC activation in case of 
an unattached chromatid (Cheeseman et al., 2006). One of the key points of MCC activation 
is the recruitment of all MCC proteins to kinetochores at the early stages of kinetochore-
microtubule attachment (Howell et al., 2004). This close proximity allows KNM to signal 
about the attachment status and generates a dynamic control system for the SAC.  
The sensory apparatus of the SAC is Mps1, which is recruited to the kinetochores by 
the help of Aurora B (Vigneron et al. 2004; Santaguida et al. 2011), the Ser/Thr kinase within 
chromosome passenger complex (CPC, explained in detail in the next section). Mps1 
phosphorylates KMN and creates docking sites for SAC proteins that are important in MCC 
assembly (Krenn et al., 2014). The main responsibility of Aurora B is sensing the unattached 
or abnormally attached kinetochores to the mitotic spindle (Lampson and Cheeseman, 
2011). The ability of Aurora B to do this does not depend on its kinase activity but depends 
more on its localisation and close proximity to the kinetochores. Although the contribution 
of Aurora B is controversial, in terms of direct or indirect activation of SAC, it certainly has a 
huge influence on the system. Furthermore, Aurora B counteracts PP1, which is considered 
as the SAC silencing phosphatase (Lampson and Cheeseman, 2011).    
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The SAC is overall a feedback mechanism generated by the unattached kinetochores, 
creating a negative signal towards the progression of mitosis. And because it is a feedback 
mechanism, it has the potential to be repeated several times in a loop, until the negative 
feedback is lost from the attached kinetochore. This may extend the prometaphase or 
metaphase stage of mitosis and delay cell division, but ensures proper distribution of 
chromosomes. 
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Figure 1.5: The components and mechanism of SAC. A. SAC components and activation 
explained. At prometaphase when the kinetochores start to attach to the spindle, any 
kinetochore that it not attached (in red) activates the SAC and MCC is assembled. APC is 
inhibited until the unattached kinetochore is safely attached. Then the SAC is turned off and 
degradation of Cyclin B and Securin is achieved, which then promotes sister chromatid 
separation. B. The cycle of MCC assembly and inactivation.  The presence of unattached 
kinetochores trigger MCC assembly and after APC inactivation, MCC disassembly is triggered. 
However, this cycle is repeated as many times as necessary until the kinetochore is safely 
attached to the spindle. (taken from Musacchio, 2015). 
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1.3.3 The chromosome passenger complex (CPC) 
 The chromosome passenger complex (CPC) is a four subunit complex responsible for 
a successful mitotic progression. The CPC localisation changes during mitosis, where it 
regulates different events like SAC and cytokinesis. The four subunits of CPC are the catalytic 
subunit Aurora B (a Ser/Thr kinase), and other regulatory components Survivin, inner 
centromeric protein (INCENP) and Borealin (Ruchaud et al., 2007).  
The assembly of CPC starts on the INCENP subunit, which is the assembly point. The 
N-teminus of INCENP along with Survivin and Borealin form a three helix bundle, which links 
the baculovirus IAP repeat (BIR) domain of Survivin and the C-terminus of Borealin 
(Jeyaprakash et al., 2007). Aurora B on the other hand, binds to the IN-BOX on the INCENP C-
terminus and gets activated (Adams et al., 2000) (Figure 1.6).  
INCENP is considered as the platform on which all other CPC components are 
assembled and it is regulated by both Aurora B and CDK1 (Cooke et al., 1987). When bound 
to INCENP, Aurora B phosphorylates it, which also leads to the full activation of Aurora B 
(Honda et al., 2003). Furthermore, phosphorylation of INCENP by CDK1 is required for polo-
like kinase 1 (PLK1) localisation to the centromere, where the activation of PLK1 is achieved 
by Aurora B at Thr210 (Goto et al., 2006; Carmena et al., 2012).  
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Once assembled, CPC phosphorylates its targets through Aurora B and its dynamic 
localisation during mitosis enables CPC to achieve these phosphorylations at the appropriate 
time and space for mitotic progression (van der Horst and Lens, 2014). At the beginning of 
mitosis, CPC is localised at the centromeres, which is necessary for a successful kinetochore-
microtubule attachment. This is achieved by activating the SAC through Mps1 (as mentioned 
in the SAC section). At metaphase-anaphase transition, CPC localizes to the equator of the 
cell (Earnshaw and Cooke, 1991), where it controls cytokinesis and the timing of nuclear 
envelope reformation after mitosis (Kitagawa and Lee, 2015; Ruchaud et al., 2007).  
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Figure 1.6: CPC components and assembly mechanism. Components of CPC and their functions are 
explained. INCENP (yellow), Survivin (green) and Borealin (blue) forming the three helix bundle and 
Aurora B (red) binding to the IN box of INCENP. The secondary structures are also shown. (Image 
taken from Carmena et al., 2012) 
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The activity of Aurora B is highly regulated as it has so many targets and 
phosphorylation of these targets must be done in a timely manner for a mitotic progression. 
An important aspect of Aurora B regulation is the counteracting phosphatases PP1 and 
PP2A-B56. At early mitosis, PP1 is recruited to the outer kinetochores by its related targeting 
subunits SDS22 (Posch et al., 2010) and CENP-E (Kim et al., 2010), while its localization to the 
bulk chromatin by Repo-Man is suppressed (Trinkle-Mulachy et al., 2006; Vagnarelli et al., 
2006). PP2AB56 on the other hand, counteracts Aurora B phosphorylation and stabilizes 
kinetochore-microtubule attachments (Foley et al., 2011).  
When the cells enter mitosis, Aurora B phosphorylates histone H3 at Ser10 and Ser28 
(Hsu et al., 2000; Murnion et al., 2001; Goto et al., 2003). This causes the release of 
heterochromatin protein 1 (HP1) from the adjacent trimethylated Lys9 of H3 (H3K9me3) 
(Fischle et al., 2005; Hirota et al., 2005). CPC localizes at the centromeres from this point 
onwards and stays there until anaphase. This localization at the centromere requires the 
mitosis specific phosphorylation of two histone tails: H3T3 by Haspin kinase and H2AT120 by 
Bub1 kinase (Yamagishi et al., 2010). H3T3 phosphorylation localizes CPC, therefore Aurora 
B, to the centromeres via the BIR domain of Survivin, which recognises H3T3ph specifically 
(Kelly et al., 2010; Wang et al., 2010; Dai and Higgins, 2005). In addition, recognition of the 
H2AT120 by Shugoshin and its interaction with CPC also promotes CPC recruitment to 
centromeres. CPC localization at centromeres creates a positive feedback loop that increases 
H3T3 phosphorylation (Figure 1.7). This positive feedback loop includes phosphorylation of 
Haspin by CDK1-Cyclin B at early mitosis, when this phosphorylation is recognised by Plk1 to 
further phosphorylate Haspin (Zhou et al., 2014: Ghenoiu et al., 2013).  
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These series of phosphorylations trigger the H3T3 phosphorylation and after being 
recognised by CPC, Haspin is even further phosphorylated by Aurora B and this enhances the 
H3T3 phosphorylation (Wang et al., 2011; Zhou et al., 2014). In the meantime the Repo-
Man/PP1 complex, that is responsible for removing H3T3 phosphorylation, is kept inactive 
until anaphase onset when CPC is released from the mitotic chromatin. The inactivation of 
the complex is achieved by CDK1-Cyclin B phosphorylation (at T412 and T419) and is kept 
away from the substrate by Aurora B phosphorylation (at S893); these phosphorylations  are 
removed by PP1 and PP2A respectively (Vagnarelli et al., 2011; Qian et al., 2013).  
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Figure 1.7: CPC-Haspin-H3T3ph feedback loop. A. Early mitosis signal when Haspin is 
phosphorylated by CDK1-Cyclin B as well as Plk1 and H3T3 phosphorylation is achieved. B. 
Signal amplification when CPC is recruited to the H3T3ph and further phosphorylates Haspin 
to enhance H3T3ph even further. Repo-Man/PP1 complex is inhibited at this stage. C. CPC 
accumulation at the centromere is increased with the contribution of H2AT120 
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1.4 Histone modifications 
Genomic DNA in eukaryotic cells is packed around histones to form nucleosomes and 
histones undergo further modifications for proper packaging of DNA into euchromatic and 
heterochromatic regions. One of the challenges for the cell when preparing for mitosis is to 
resolve all these levels of organisation on the histones for timely condensation of 
chromosomes then to re-organise the interphase chromatin. The cell also needs to have a 
memory of the previous modifications so that the exact same ones could be maintained (Egli 
et al., 2008).  
Histone modifications include phosphorylation, methylation, acetylation and 
ubiquitylation (Kouzarides, 2007). These modifications change the biophysical properties of 
the nucleosomes, exposing parts of DNA that need to be transcribed and recruiting 
necessary proteins or hiding the parts of DNA that are not transcribed, therefore preventing 
any other protein to reach that particular part of the genome. Most of these modifications 
occur at the N or C terminal tail of histones, which allows other proteins to access and 
recognise them (Wang and Higgins, 2013).  For each type of modifications, there are specific 
group of proteins that create the mark and another group of proteins that recognise that 
mark. In other words, histones are marked at specific places for specific proteins to 
recognise and follow orders. Some modifications are increased as the cells go into mitosis 
and similarly some are decreased but for a successful mitotic exit, several modifications are 
rapidly removed at appropriate times. Table 1.1. summarise some important histone 
modifications, the proteins responsible for these and their significance. 
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Phosphorylation of histones usually results in either recruitment of a specific protein 
to the area or release of a protein from the same area. For example, H3T3 phosphorylation 
by Haspin triggers recruitment of CPC to centromeres (Dai et al., 2005; Wang et al., 2011), 
whereas H3S10 phosphorylation by Aurora B triggers the release of HP1 from the adjacent 
H3K9me3 and this is referred to as a phosphor-methyl switch (Fischle et al., 2005; Hirota et 
al., 2005; Wang and Higgins, 2013). Similarly, recruitment of multiple proteins as a result of
Modification Enzyme Comments 




H3T3ph Haspin CPC(Survivin) 
recruitment onto 
chromatin 
H3S10ph Aurora B Displacement of HP1 
from chromatin 
H3S28 Aurora B Displacement of 
PRC1 






H3K27me3 Ezh2 Bookmarking 
polycomb genes, 
PRC1 and PRC2 
binding 
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 histone phosphorylation may result in a series of phosphorylations between the proteins, 
which then activates or inactivates several signalling cascades. 
Methylation of lysine (mono, di and tri) and arginine residues on the histones are 
mostly repressive markers that form heterochromatin, while acetylation on the other hand, 
marks the regions that are actively transcribed. Acetylation therefore is a lot more dynamic 
than methylation (Kouzarides, 2007). Ubiquitinylation of histones does not trigger 
degradation as it does with other proteins; instead, it may trigger gene repression and 
heterochromatin maintenance (Wang et al., 2004; Racine et al., 2012).   
 At mitotic exit, the re-establishment of histone acetylation and removal of 
phosphorylation are very important in order to resume gene transcription. PP1 plays an 
important role, counteracting most of the mitotic kinases including CDK1-Cyclin B, Aurora B, 
Haspin and Plk1. PP1, along with its targeting subunit Repo-Man, is recruited to anaphase 
chromatin at high levels to remove H3T3, H3S10 and H3S28, as the CPC is removed from 
chromatin (Vagnarelli et al, 2011, Qian 2011, Qian 2015, De Castro et al, 2016).  
 It has been well documented that histone modifications trigger replacement and 
recruitment of proteins to the chromatin and these facilitate chromosome condensation and 
segregation. This information is also transmitted to the daughter cells for the exact same 
histone modifications to take place. 
  37 
 1.5 Function and regulation of Repo-Man 
1.5.1 Repo-Man as a PP1 targeting subunit 
Repo-Man is a PP1 targeting subunit which is coded by the CDCA2 (Cell division cycle 
associated 2) gene on chromosome 8 (8p21.2). It is named so, because it is responsible for 
recruiting PP1 onto mitotic chromatin at anaphase onset (Recruits PP1 onto Mitotic 
chromatin at anaphase) (Trinkle-Mulcahy 2006). Repo-Man coordinates chromosome 
organisation and dynamics during mitosis and nuclear envelope reassembly during mitotic 
exit (Vagnarelli et al., 2011). The C terminal domain localizes Repo-Man to bulk chromatin in 
early anaphase to target PP1 for de-phosphorylation of histone H3 and the N terminal 
domain localizes Repo-Man to the chromosome periphery in late anaphase where it helps 
reassembly of the nuclear envelope by recruiting nuclear envelope proteins like Importinβ 
and Nup153 in a PP1 independent manner (Vagnarelli et al., 2011).  
At the onset of mitosis, Repo-Man is found to be dispersed in the cytoplasm, whereas 
at anaphase onset it is observed to be highly associated with chromatin, where it targets PP1 
through its RVTF motif (Figure 1.8). It was reported that when the RVTF motif is mutated, 
Repo-Man PP1 binding is completely abolished but this mutation only affects Repo-Man 
binding to PP1 and not to chromatin. Furthermore, Repo-Man was proven to be vital for cell 
viability as its absence induces apoptosis and this was shown by RNA interference (Trinkle-
Mulachy et al., 2006).  
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Repo-Man/PP1 complex de-phosphorylates histone H3 at Thr3 (Vagnarelli et al, 2011, 
Qian et al 2011) Ser10 (Vagnarelli et al, 2011) and Ser28 (de Castro et al, 2016) which are 
substrates for Haspin and Aurora B kinases respectively (Dai and Higgins, 2005; Dai et al., 
2006; Dai et al., 2005). Association of Repo-Man with the chromatin is very dynamic in early 
mitosis and the system favours Repo-Man to stay OFF the chromatin, whereas towards 
mitotic exit the system favours Repo-Man to be loaded ON the chromatin (Figure 1.9). This 
was shown by FRAP analysis using interphase and metaphase chromatin in HeLa cells that 
transiently express GFP:Repo-Man. The recovery of the signal in metaphase was reported to 
be a lot more dynamic than in interphase (Vagnarelli and Earnshaw, 2012).  
Repo-Man contributes to a successful mitotic exit not only by de-phosphorylating 
histone H3, but also by regulating chromosome architecture along with condensin during 
mitosis. When chromosome condensation is promoted by an unknown RCA factor (Regulator 
of chromosome architecture), condensin complex (1 and 2) associates with chromosomes 
and its absence causes abnormalities in chromosome condensation. These abnormalities can 
be prevented by either blocking PP1 recruitment onto chromatin by Repo-Man as PP1 
recruitment inactivates RCA and blocks condensin accumulation, or by inducing high CDK1 
activity (Vagnarelli et al., 2006). Blocking PP1 recruitment by Repo-Man is achieved by 
mutating the RVTF motif (RAXA mutant) (Trinkle-Mulachy et al., 2006). 
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Figure 1.8: Repo-Man localisation throughout the cell cycle. Repo-Man (green) is nuclear at 
interphase and disperses as the cells enter mitosis. Repo-man is kept away from the mitotic 
chromatin until anaphase, when where it is stably associated with mitotic chromatin. DNA 
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Figure 1.9: A diagram showing the regulation of Repo-Man/PP1 complex throughout 
mitosis. At early mitosis Repo-Man phosphorylation occurs at a high level, which favours 
towards keeping Repo-Man OFF the chromosomes, whereas at late mitosis, Repo-Man is 
released from phosphorylations, which favours the Repo-Man/PP1 complex to load onto 
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1.5.2 Regulation of Repo-Man throughout mitosis 
Repo-Man activity is controlled by CDK1-Cyclin B phosphorylation on T412 and T419 
(Vagnarelli et al., 2011). Phosphorylated Repo-Man has low affinity for chromosomes and 
this prevents early recruitment of Repo-Man to mitotic chromatin. In fact, it was shown that 
when CDK1-Cyclin B phosphorylation sites are mutated to phospho-deficient Alanine, Repo-
Man localizes on mitotic chromatin early at prometaphase/metaphase (Vagnarelli et al., 
2011). CDK1-Cyclin B phosphorylation is also important for regulating the binding of PP1 to 
Repo-Man. It is, in a way, a mechanism to make sure the Repo-Man/PP1 holoenzyme is not 
fully activated before anaphase onset. The activation of the complex at the right time is 
important to maintain sufficient H3 phosphorylation on chromosomes. Full activation of the 
complex is achieved when Repo-Man is de-phosphorylated by PP1 itself. This makes Repo-
Man both a substrate and a targeting subunit for PP1 (Vagnarelli, 2014).  
Another phosphorylation of Repo-Man is achieved by Aurora B kinase at Ser893, 
which was reported to be de-phosphorylated by PP2A and play and important role in Repo-
Man recruitment on chromosomes (Qian et al., 2013). When phosphorylated at this site, 
Repo-Man localisation on mitotic chromatin is blocked. Similar to the CDK1 sites, when this 
Aurora B site is mutated to the phospho-mimetic Aspartic Acid, Repo-Man did not localise on 
chromatin even when it is meant to at mitotic exit. These regulation sites on Repo-Man 
indicate that the control of the complex is achieved through phosphorylation of Repo-Man 







Figure 1.10: A diagram showing Repo-Man binding domains. N terminal domain of Repo-
Man regulates its interaction with nuclear membrane proteins, whereas the C terminal 
domain regulates its binding to chromatin as well as its interaction with ATM kinase. 
Furthermore, two more important domains are placed towards the C terminal site where the 















In addition, a recent study showed that the S400 residue on Repo-Man might 
contribute to its localisation and might be phosphorylated as well. Indeed, phospho-mimetic 
mutations on this site combined with the CDK1 sites (T412 and T419) keep Repo-Man OFF 
the mitotic chromatin and similarly the phospho-deficient mutations on the same sites cause 
pre-mature localisation of Repo-Man onto the chromatin (Qian et al., 2015). Although this 
suggests that S400 phosphorylation may contribute towards Repo-Man localisation on 
chromatin, it is still not clear which kinase is responsible from its phosphorylation.  
The sites that are de-phosphorylated by Repo-Man/PP1 complex have different 
functions. Among these sites Thr3 represents the docking site for the Chromosome 
Passenger Complex (CPC) thus de-phosphorylation of this site is important for the 
inactivation of the spindle assembly checkpoint (Yamagishi et al., 2010; Wang et al., 2010; 
Kelly et al., 2010; Jeyaprakash et al., 2007). The Ser10 mark on the other hand, is involved in 
the regulation of heterochromatin protein 1 (HP1) binding. HP1 recognizes the methylated 
H3K9 and directs heterochromatin formation (Fischle, 2005; Hirota et al., 2005). When Ser10 
is phosphorylated by Aurora B, HP1 is dissociated from heterochromatin and re-associated 
after de-phosphorylation of Ser10 by Repo-Man/PP1 complex. This is an important function 
of Repo-Man in organizing heterochromatin environment in post-mitotic cells (Vagnarelli et 
al, 2011; De Castro et al, 2016).  
Overall, Repo-Man is considered to be one of the important players in mitotic exit, as 
its activity is necessary for a successful mitotic exit as well as cell viability. It has also been 
reported to play an important role in nuclear envelope reformation (explained in detail in 
the Repo-Man and nuclear envelope section) and to be overexpressed in several cancers 
(explained in detail in the Repo-Man and cancer section).  
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1.6 Nuclear envelope dynamics during mitosis 
1.6.1 Nuclear envelope proteins 
The nuclear envelope (NE) is formed of the inner nuclear membrane (INM), the outer 
nuclear membrane (ONM) and the perinuclear space in between. INM is a complex 
structure, which is composed of lamins (type A and B), nuclear lamin-associated membrane 
proteins (LAP1/LAP2), lamin B receptor (LBR) and emerin. INM serves as a dock for proteins 
like BAF and HP1 (heterochromatin protein 1) and helps these proteins to provide a link 
between the lamina and the chromatin, whereas ONM extends to the endoplasmic 
reticulum (ER) towards the cytoplasm (Figure 1.10). The open spaces in the NE are occupied 
by the nuclear pore complexes (NPCs), which provide the rapid transport of proteins out of 
the nucleus, into the cytoplasm, and are formed of nucleoporins (Nups) (de Castro et al., 
2016).  
Mammalian cells require a series of complicated events during mitosis. Since they 
undergo an open mitosis, disassembly and reassembly of the nuclear envelope are critical to 
let the chromosomes interact with the mitotic spindle and both require major reorganization 
and instrumentation of related proteins. Nuclear envelope breakdown (NEBD) is achieved by 
phosphorylation of the NPCs and lamins and by mechanical disruption, achieved by the 
mitotic spindle (Burke and Ellenberg, 2002). At the end of this process, the mitotic chromatin 
is free to attach the mitotic spindle. However, it is also critical that after mitosis, the 
phosphorylations are reversed for the re-formation of the NE. 
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Several kinases are involved in NEBD. One of them is cyclin dependent kinase 1 
(CDK1), which targets the type-A lamins in early prophase (Peter et al. 1990) and another 
one is protein kinase C, which targets type-B lamins in late prophase (Heald and McKeon 
1990). The phosphorylation dynamics on lamins are important for the dissociation of 
chromatin from the NE. Nucleoporins of the NPC are also phosphorylated by several kinases 
to complete the full breakdown and dissociation of NE (Laurell et al. 2011).  
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Figure 1.11: Structure and layers of the nuclear envelope. The structural units of the 
nuclear envelope (NE) are shown. The inner (nucleus) and outer (cytoplasm) nuclear 
membrane (INM and ONM) are separated by the nuclear pore complexes (NPC) and pore 
proteins as well as INM proteins and lamins. Lamins form the nuclear lamina underlying the 
INM, and these are anchored by transmembrane proteins to the peripheral chromatin. 
Nesprin, lamina-associated proteins 1 and 2 (LAP1 and LAP2), emerin, the lamin B receptor 
(LBR) and MAN1 are nuclear envelope proteins that are bound to the lamina. Transcription 
factors are also present, including sterol response element binding protein (SREBP1), the 
retinoblastoma transcriptional regulator (RB), germ cell-less (GCL), FOS and MOK2. Barrier to 
autointegration factor (BAF) also binds to the nuclear lamina. Heterochromatin protein 1 
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1.6.2 Repo-Man and nuclear envelope 
 
 PP1 and PP2A are known to be involved in NE reassembly at M/G1 transition. 
Especially PP1 was reported to be involved in the de-phosphorylation of Lamin B (Thompson 
et al., 1997) and with the help of its targeting subunit A-kinase anchoring protein (AKAP149). 
PP1 is recruited at the nuclear envelope for a successful reassembly (Steen et al., 2000). 
Hence, PP1 targeting to the NE is a pre-requisite for NE reassembly. The phosphatase 
responsible for the de-phosphorylation of NUPs on the other hand, remains unknown. 
However, there is evidence that NUP153 and NUP50 interacts with PP1 and its targeting 
subunit Repo-Man (Moorhead et al., 2007; Vagnarelli et al 2011; de Castro et al, 2016).  
 Repo-Man was found to interact directly with Importin β and this binding was 
abolished upon phosphorylation of Repo-Man by CDK1 at the N terminal domain. This 
interaction was reported to be important for the targeting of Importin β to the chromosome 
periphery and it does not depend on the catalytic activity of Repo-Man/PP1 complex 
(Vagnarelli and Earnshaw, 2012; Vagnarelli et al., 2011). In addition, Repo-Man was also 
found to interact with NUP153 and NUP50 at mitotic exit, and this interaction is important 
to maintain a pool of Repo-man a repressive chromatin environment at the nuclear 
periphery (de Castro et al, 2016). 
 Since Importin β levels are critical for NE reassembly (Walther et al., 2003; Harel et 
al., 2003), targeting it to the NE is a crucial step and this makes Repo-Man an important 
player of NE reassembly after mitosis. Moreover, a pool of Repo-Man was observed to 
localize at the chromosome periphery after anaphase, and at the rim of the NE at 
interphase. Furthermore, Repo-Man depletion compromises the morphology of the NE 
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possibly due to the inability of targeting Importin β to the chromosome periphery during NE 
reassembly, as shown by Lamin A/C staining (Vagnarelli et al., 2011).  
 Although there is sufficient data to conclude that Repo-Man is important for NE 
reassembly, it is not the only regulator and Repo-Man recruitment only is not sufficient to 
trigger the complete reassembly pathway (Vagnarelli et al, 2011). There are other key 
proteins to consider like ELYS-MEL28, which mediates incorporation of some NUPs into the 
NE (Guttinger et al., 2009), and the lamins. However, it is tempting to speculate that the 
localisation of a phosphatase to the NE could potentially be important to de-phosphorylate 
other relevant NE targets.   
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1.6.3 Regulation of Lamin A/C throughout the cell cycle 
Lamin A/C, coded by the LMNA gene, is a member of intermediate filament proteins 
(IFs), which share a structurally conserved rod domain, and variable head and tail regions 
(Eriksson et al., 2009).  Expression of Lamin A/C is highly regulated and it depends on 
differentiation. Further to its role as a nuclear shaper, Lamin A/C also has other defined 
binding partners that are related to transcription and signalling, including DNA and histone 
proteins (Simon and Wilson, 2013). Its ability to bind to DNA directly or indirectly, may 
indicate that it is one of the important regulators of the chromatin environment (Dechat et 
al., 2008).  
 Regulation of Lamin A/C is achieved via post-translational modifications throughout 
the cell cycle. The most substantial of these is phosphorylation but other modifications like 
sumoylation, acetylation and farnesylation were also reported (Snider and Omary, 2014; 
Simon and Wilson, 2013). There are 70 unique phosphorylation sites on Lamin A/C and it is 
well-known that phosphorylation of lamins occurs continuously throughout the cell cycle, 
during both interphase and mitosis. So far, functions of these phosphorylations have been 
explained in terms of nuclear targeting or assembly/disassembly of lamins (Luscher et al., 
1991; Ottaviano and Gerace, 1985; Rzepecki et al., 2002).  
As mentioned before, CDK1 directly phosphorylates Lamin A/C during mitosis (Peter 
et al., 1990). The mitotic sites S22 (N terminus) and S392 (C terminus) have been shown to 
promote disassembly of nuclear lamina when phosphorylated (Heald and McKeen, 1990). 
Among these sites, S22 has been shown to be more important as it promotes head-to-tail 
de-polymerization, whereas the N terminal S392 is not sufficient on its own (Luscher et al., 
1991).  
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CDK5 (cyclin dependent kinase 5) has also been reported to phosphorylate Lamin A/C 
at the mitotic sites to induce neuronal apoptosis (Chang et al., 2011), and AKT has been 
shown to phosphorylate Lamin A/C at S404 to regulate LNMA gene expression (Bertacchini 
et al., 2013). Considering the number of phospho-sites on Lamin A/C, it is likely that there 
are more kinases to be identified which are involved in its regulation.  
A recent study showed that Lamin A/C is phosphorylated not only in mitosis but also 
in interphase. Interphase phosphorylation is concentrated on the head, the beginning of the 
tail and the end of the tail (Kochin et al., 2014). It was also reported in this study that some 
of the interphase phospho-sites are also the sites known as the mitotic sites (S22 and S392). 
Western blot and immunofluorescence analyses on these sites revealed that they are indeed 
phosphorylated at interphase, but as expected, at a much lower rate than during mitosis. 
Furthermore, mutation analyses showed that several serine residues on Lamin A/C are 
important for its association with the nuclear lamina as well as its mobility and localization. 
Phosphorylated LaminA/C was found to be more mobile than the un-phosphorylated protein 
(Kochin et al., 2014). 
After mitosis, reversal of all the events depends on de-phosphorylation of all targets, 
so that re-association of the NE can take place. It is known that Protein phosphatase 1 (PP1) 
is recruited at the periphery of the chromosomes at telophase to direct de-phophorylation 
of Lamin B by its targeting subunit AKAP149 (Thompson et al. 1997; Steen et al. 2000). 
Another targeting subunit Repo-Man de-phosphorylates importin β and targets it to NE 
(Vagnarelli et al. 2011; Qian et al, 2015). Protein phosphatase 2A (PP2A) is also involved by 
de-phosphorylating Barrier to autointegration factor (BAF) and allowing it to re-associate 
with chromatin (Asencio et al. 2012). Although Lamin A/C was observed to localize at some
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 chromosome regions at early anaphase, where it extends at a later stage, (Haraguchi et al. 
2008; Dechat et al. 2004), there is not information on its de-phosphorylation.  
It has been recently reported that the re-assembly of Lamin A/C after mitosis 
depends on its SUMO-interacting motif (SIM). In this study, Moriuchi et al. identified one of 
the SIMs on Lamin A/C as an important facilitator for its interaction with SUMO isoforms. 
They also report that this motif is essential for Lamin A/C recruitment on the chromosomes 
but most importantly, it is necessary for de-phosphorylation of the S22 at the end of mitosis 
(Moriuchi et al., 2016). Although it is still not quite clear which phosphatase or phosphatases 
are involved, this study proves that sumoylation of Lamin A/C may serve as a specific signal 
and promote its interaction with phosphatases at the end of mitosis.  
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1.7 Repo-Man and cancer 
The first correlation between Repo-Man and cancer progression was proposed when 
expression profiling of more than a hundred neuroblastoma tumours was published 
(Krasnoselsky et al., 2005). This study showed Repo-Man among the top scored genes that 
are overexpressed in stage 4 neuroblastoma tumours. Furthermore, at protein level, Repo-
Man overexpression was found to correspond with N-Myc expression in neuroblastoma cells 
and the survival curve of neuroblastoma patients with high and low levels of Repo-Man 
showed that high levels of Repo-Man corresponds with poor prognosis (Vagnarelli, 2014). 
Although the mechanism behind this effect is not known, this is the indication that Repo-
Man may be used as a diagnostic marker for neuroblastoma.  
Another gene expression profiling on melanoma cell lines revealed signature genes 
that are associated with melanoma progression. These genes include the cell cycle 
progression genes that are upregulated and genes related to DNA replication and repair. 
Repo-Man was included in this list of signature genes but no further studies were done to 
understand the relevance in detail (Ryu et al., 2007). 
Repo-Man was identified as a gene that correlates with the metastatic behaviour of 
synovial sarcoma (SS) as well. The importance of the t(X;18) translocation in SS is well 
established however the genetic basis is not clear. With the study that was performed on 
metastatic and non-metastatic SS tumours for a gene expression profiling comparison, Repo-
Man, together with KIF14, was identified as a top ranked gene that drives metastasis of SS, 
which is more common in adults than children (Legarde et al., 2013). 
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The most striking study that links Repo-Man with cancer progression was on breast 
cancer cells. Normal, malignant and metastatic breast cancer cells were compared for Repo-
Man expression and the results showed that malignant and metastatic breast cancer 
tumours have high levels of Repo-Man. Furthermore, depletion of Repo-Man stopped 
growth of malignant MCF10A-CA1h breast cancer cell line in soft agar (Peng et al., 2010), and 
arrested squamous cell carcinoma cells at G1, leading to apoptosis (Uchida et al., 2013). 
These were the first studies suggesting that Repo-Man could potentially become a 
therapeutic target for breast cancer and other cancers, as its absence was strikingly effective 
towards negatively regulating cell proliferation in cancer cells.  
Repo-Man has also been suggested to be involved in DNA damage response and was 
shown to interact with ATM kinase in a PP1 dependent manner. In Xenopus oocytes and egg 
extracts, Repo-Man was shown to interact with ATM but this interaction does not seem to 
be conserved in other systems as the same results were not confirmed in DT40 and HeLa 
cells (Peng et al., 2010). In Xenopus system, Repo-Man was found to target PP1γ at the DNA 
damage site and negatively regulate the DNA damage response. The release of Repo-Man 
from the site and dissociation from active ATM leads to an increased DNA damage response. 
Repo-Man role in DNA repair mechanism can also contribute to its properties as a cancer 
driver gene, as it can provide a platform for mutations and chromosome rearrangements 
and therefore trigger tumour formation.  
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In addition, Repo-Man also controls chromosome segregation and counteracts 
Aurora B kinase, which may lead to aneuploidy and lagging chromosomes. As mentioned 
before, Repo-Man is one of the important players of mitotic exit and any defect in its 
function, is likely to make the cells more susceptible to accumulate mutations due to hyper-
phosphorylation of Histone H3. Moreover, since Repo-Man is involved in de-phosphorylating 
histone H3, its loss of function could cause problems in chromatin organization after mitosis 
and defects in heterochromatin environment.  
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2.1 Tissue Culture 
HeLa cells were cultured in DMEM high glucose, GlutaMAX™ supplement (Gibco) 
with addition of 10% foetal bovine serum (Labtech) and 5% penicillin/streptomycin (Gibco), 
at 370C in 5% CO2 humid incubator. The cells were passaged (1:10) every time they reached 
80-90% confluency by trypsinization (TryplE, Gibco). 
Chicken B cell lymphoma DT40 cells were cultured in RPMI 1640 Medium, L-
Glutamine (Gibco) with addition of 10% foetal bovine serum (Labtech), 5% 
penicillin/streptomycin (Gibco) and 1% chicken serum, at 390C in 5% CO2 humid incubator. 
The cells were passaged (1:25) once every two days when they reached 90% confluency. 
HCC1143 triple negative breast cancer and CA1h malignant breast cancer cell lines 
were cultured by Lorena Ligammari. Wound healing assays with these cell lines were also 
performed by her. 
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2.2 Site Directed Mutagenesis 
All mutations were performed by using GENEART® Site-Directed Mutagenesis System 
and AccuPrime™ Pfx DNA Polymerase (Invitrogen). The DNA concentration to be used was 
optimised to 100ng/µl and a PCR mixture was prepared for each reaction (Table 2.1) by using 
specifically designed oligonucleotides (Eurofins Genomics, Germany) (Table 2.5) and the 
reaction was performed by following suggested PCR parameters (Table 2.2). 
 
       Table 2.1: Components of the PCR mix 
Component Volume Final Concentration 
10X AccuPrime™ Pfx Reaction 
mix 
5 µL 1X 
10X Enhancer  5 µL 1X 
Primer mix (10 µM each) 1.5 µL 0.3 µM each 
Plasmid DNA (100 ng/µL) 1 µL 100ng 
DNA Methylase (4 U/µL) 1 µL 4 units 
25X SAM 2 µL 1X 
AccuPrime™ Pfx (2.5 U/µL) 0.4 µL 1 unit 
PCR water to 50 µL  
        
Following the PCR, a recombination reaction (20µl total volume) was performed 
(Table 2.3) for 10 min at room temperature (stopped by adding 1 µL 0.5 M EDTA) and 2µl of 
this reaction was used for the transformation reaction.  
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    Table 2.2: Parameters for PCR 
Temperature Duration Number of Cycles 
370C 20 min 
1 
940C  2 min 
940C 20 sec 
18 57
0C 30 sec 
680C 30 seconds/kb of 
plasmid 
680C 5 min 1 





                  Table 2.3: Components of the recombination reaction mix  
Component Volume Final Concentration 
5X Reaction Buffer 4 µL 1X 
PCR water  10 µL - 
PCR Sample 4 µL - 
10X Enzymer Mix 2 µL 1X 
 
 
One Shot® MAX Efficiency® DH5α™-T1R competent cells (provided with the kit) were 
used for all transformation reactions. After adding 2µl of the recombination reaction on 
competent cells, the cells were incubated on ice for 12 min, at 420C for 30 sec and again on 
ice for 2 min. Samples were then removed from ice and 250 µL of pre-warmed SOC medium 
was added. After one hour of incubation at 370C (shaking), the samples were plated on LB-
Agar plates containing the correct antibiotic without performing any dilutions and left 
overnight at 370C to grow. 
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The next day, colonies were picked and grown in LB media overnight with the 
appropriate antibiotic. DNA was extracted from these cultures and sent for sequencing. The 
colony that had the mutation was then grown further and the mutated plasmid DNA was 
extracted by following a midi prep kit without any optimisations (Qiagen midi prep kit, USA). 
 
 
             Table 2.4: List of the mutations performed. 
Name Mutation Plasmid 
3A S400A:T412A:T419A GFP:RMwt (pEGFPc1) 
3D S400D:T412D:T419D GFP:RMwt (pEGFPc1) 
FA F404A GFP:RMwt (pEGFPc1) 
Res2 (oligo res) T177T:L179L:T180T:R181R GFP:RMwt (pEGFPc1) 
3ARes T177T:L179L:T180T:R181R GFP:3A (pEGFPc1) 
3DRes T177T:L179L:T180T:R181R GFP:3D (pEGFPc1) 
4ARes T177T:L179L:T180T:R181R GFP:3ARes (pEGFPc1) 
4DRes T177T:L179L:T180T:R181R GFP:3DRes (pEGFPc1) 
FARes T177T:L179L:T180T:R181R GFP:FA (pEGFPc1) 
IRCE K762R GFP:RMwt (pEGFPc1) 
IKCA E764A GFP:RMwt (pEGFPc1) 
GST-CtermIRCE K762R GST:CtermRM (pGEX-4T) 
GST-CtermIKCA E764A GST:CtermRM (pGEX-4T) 
RVDF T394D GFP:Laci:RMwt (pEGFPc1) 
2ARes S400A:S407A GFP:Res2 (pEGFPc1) 
IRCERes T177T:L179L:T180T:R181R GFP:IRCE (pEGFPc1) 
IKCARes T177T:L179L:T180T:R181R GFP:IKCA (pEGFPc1) 
1ARes S407A GFP:Res2 (pEGFPc1) 
PP1gR20Q R20Q RFP:PP1gwt (pEGFPc1) 
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Table 2.5: List of oligonucleotide sequences used for mutation analyses. 























T394D FW- aagaggaagagagttgcatttggagaggactta 
Rev- taagtcctctccaaatgcaactctcttcctctt 
T419A FW- ttgcgtaaaggaggagcacctgtttgtaaaaaa 
Rev-ttttttacaaacaggtgctcctcctttacgcaa 
T412D FW- tctttgccagcaaatgatccattgcgtaaagga 
Rev-tcctttacgcaatggatcatttgctggcaaaga 
T412A FW- tctttgccagcaaatgatc cattgcgtaaagga 
Rev- tcctttacgcaatggatcatttgctggcaaaga 








2.3.1 Transfections using jetPRIME® reagent 
All transient transfections with HeLa cells were performed by using the jetPRIME® 
reagent (Polyplus). Cells were seeded on 6-well tissue culture plates (105 cells/well) on the 
first day and left to grow for 24 hrs in 2ml media. On the second day, the transfection 
mixture was prepared for each reaction (2µg DNA diluted in 200µl of jetPRIME® buffer) 
correct amount of siRNA (110pmoles) was also added to this mixture if necessary (Table 2.6) 
and 4µl of jetPRIME® reagent was added to each mixture. After 10 min of incubation at 
room temperature, the transfection mixture was added directly to the media and the cells 
were left to grow for 48 hrs. 
     Table 2.6: List of siRNA sequences used in transfection experiments. 
Name Sequence 5’-3’ 
Repo-ManUL UGACAGACUUGACC 
Repo-Man 5 Hs_CDCA2_5 (Qiagen) 
Control  CGUACGCGGAAUACUUCGAdTdT 
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2.3.2 Electroporation 
 All transient transfections with chicken B cell lymphoma DT40 cell line were 
performed by using Neon™ transfection system. Correct volume of cells (containing 5x106 
cells/transfection) was harvested and washed with PBS. The cell pellet was resuspended in 
100µl of Buffer R (provided with the kit) and 10µg of DNA was added to the mixture. The 
cells were picked up with the Neon™ pipette by using Neon™ tips and exposed to electric 
current (1600V, 10ms, 3 pulses) in the Neon™ cuvette filled with 3ml of Buffer E (provided 
with the kit). Cells were then left to grow in 10ml of media without antibiotics in T25 tissue 
culture flasks for 24 hrs. 
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2.3.3 Generating stable cell lines 
 HeLa stable cell lines were generated using the jetPRIME® reagent. The cells on 6-
well tissue culture plates were transfected with a plasmid DNA coding fluorescent tagged 
protein of interest  as described before and left to grow for 24 hrs. After 24 hrs, the cells 
were trypsinized and resuspended in 2ml of media and transferred to 100mm tissue culture 
dishes containing 10ml of media (5 dishes for each well, 400µl of cells in each dish). Correct 
amount of G418 selection (Gibco, 1:25, 2mg/ml final concentration) was then added to each 
dish and the cells were left to grow for a minimum of 10 days. At the end of the selection 
process, the colonies were collected and further grown separately. Each colony was 
observed under the fluorescent microscope and colonies that expressed the fluorescent tag 
were selected. 
 DT40 stable cell lines were generated using Neon™ transfection system. The cells 
were transfected with the desired plasmid that contains a fluorescent tagged protein as 
described previously and left to incubate for 24 hrs. At the 24 hr time point, cells were put in 
G418 selection (Gibco, 1:25, 2mg/ml final concentration) in a total volume of 50ml and 
seeded onto 96-well plates (100µl/well) and left to grow for a minimum of 10 days. At the 
end of the selection process, the colonies were collected and further grown. Each colony 
was observed under the fluorescent microscope and positive colonies were selected.  
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2.4 Immunofluorescence  
 After transfecting the cells on tissue culture plates as described previously and 
applying drug treatments if necessary (Table 2.8), they were fixed with 4% PFA for 5 min. 
HeLa cells were transfected in tissue culture plates containing cover slips and fixed directly 
on the plate, whereas DT40 cells were transferred to a poly-l-lysine microscope slides to 
provide surface attachment 24hrs after the transfection. After fixation, cells were washed 
with PBS and blocked in 1% BSA for 30 min at 370C (100µl/slide).  
Antibody dilutions were prepared in 1% BSA (Table 2.7) and the primary antibody 
was applied for 30 min at 370C after blocking (80µl/slide). The cells were then washed with 
PBS (3 times for 5 min) and incubated with the secondary antibody for 30 min at 370C 
(80µl/slide). After another PBS wash, HeLa cover slips were mounted on slides and DT40 
slides were covered with cover slips with the addition of Vectashield. All the slides were kept 
at 40C to be observed and imaged with the fluorescent microscope.  
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 Table 2.7: List of antibodies used for immunostaining experiments. 
Antibody Species Dilution Company Catalog number 
H3T3ph Rabbit 1:1000 Millipore 04-746 
ACA  Human 1:1000 - - 
c-myc Rabbit 1:800 Abcam ab32072 
Aurora A Rabbit 1:200 Abcam ab12875 
Lamin A/Cph Rabbit 1:500 Cell Signaling 
Technologies 
13448 
Lamin A/C total Rabbit 1:250 Abcam ab108595 
γTubulin Mouse 1:1000 Cell Signaling 
Technologies 
5886 
αTubulin Mouse 1:1000 Cell Signaling 
Technologies 
3873 


















                        Table 2.8: List of drugs used for immunostaining experiments. 
Name Function Final 
Concentration 
Nocadazole Blocks polymerization 
of microtubules 
20μM 
ZM447439 Aurora B inhibitor 20μM 
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2.5 Cloning 
 
2.5.1 Primer design and PCR 
 All cloning primers were designed specifically for each experiment and ordered from 
Eurofins Genomics (Table 2.11). PCR was prepared by using the standard Taq DNA 
polymerase and buffer (NEB, UK), dNTP mix (NEB,UK), appropriate plasmid DNA and primers 
designed previously to a final volume of 50µl (Table 2.9). The reaction was carried out 
following the correct parameters (Table 2.10). When the reaction was terminated, 5µl of all 
PCR samples were run on an agarose gel (1%). 
 
Table 2.9: PCR ingredients and concentrations. 
Name Stock Concentration Amount Used (µl) Final Concentration 
Standard taq 
buffer 
10X 5 1X 
dNTP 10mM 1 0.2mM 
Forward primer 100µM 1 2µM 
Reverse Primer 100µM 1 2µM 
Standard taq 
polymerase 
5000 units/ml 0.25 25 units/ml 
Nuclease free 
water 
- Up to 50µl - 
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                 Table 2.10: PCR parameters for cloning experiments. 
Temperature Duration Number of Cycles 
950C 30 sec 1 
950C 30 sec 
30 
Tm of the primer 
pair (see Table 2.11) 
1 min 
680C 30 seconds/kb of 
plasmid 
680C 5 min 1 
40C forever 1 
 
 
Table 2.11: List of oligonucleotides used for cloning experiments. 




GSTRMFW tttgagtccggagaggacttaagcccggaa BamHI 57 
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2.5.2 Cloning into pGEM®-T Easy vector system 
 The amount of PCR reaction to be ligated into pGEM®-T Easy vector system 
(Promega, USA) was calculated by referring to the 5µl PCR product run on the agarose gel. 
The weight and intensity of the band were used to calculate the concentration of the PCR 
product and the ligation reaction was prepared as recommended and left overnight at 40C 
(table x). All reagents, except the PCR product, were provided with the kit. 
 After the overnight incubation, all 15µl of the ligation reaction was used to transform 
E.Coli DH5α competent cells (see later for protocol). The ligation reaction was added directly 
on top of 100µl of competent cells and mixed gently. The cells were then incubated on ice 
for 30 min, heat shocked at 420C for 30 sec, put back on ice for 5 min and diluted in 250µl of 
SOC medium (see later for recipe). After one hour incubation at 370C (shaking, 225rpm) all of 
the transformation reaction was plated on LB agar plates (see later for recipe) with 
Ampicillin (50µg/µl, Fisher, UK), X-gal (1.25%, Fisher, UK) and IPTG (1M, Fisher, UK) and left 
overnight in the 370C incubator to grow. The next day white colonies were collected to be 
grown overnight in LB and plasmid DNA was extracted from grown cultures (MoBio mini 
prep kit, USA). The extracted plasmid DNA was then used for a digestion reaction to check if 
the insert was successfully ligated into pGEM®-T Easy vector system. A reaction was 
prepared by using the appropriate enzymes (1µl each, NEB, UK), reaction buffer (6µl, NEB, 
UK), BSA (3µl, NEB, UK), plasmid DNA (1µg) and nuclease free water (up to 50µl, Thermo 
Scientific, UK) and incubated at 370C for 3 hours. After the incubations, samples were run on 
agarose gel (1%) and positive clones were grown further to get high quality DNA (Qiagen 
midi prep kit, USA). 
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        Table 2.12: Reagents for pGEM®-T Easy vector system ligation reaction. 
Reagent Amount required for 
ligation reaction (µl) 
Amount required for 
control reaction (µl) 






PCR product Calculated for 1:3 ratio - 
T4 DNA Ligase 1 1 
Nuclease free 
water 
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2.5.3 Cloning from pGEM®-T Easy vector system into another 
plasmid 
 To clone a fragment from pGEM®-T Easy vector system into another plasmid, the 
pGEM®-T Easy vector and the recipient plasmid were digested separately with appropriate 
enzymes. A reaction was prepared by using the enzymes (2µl each, NEB, UK), reaction buffer 
(6µl, NEB, UK), BSA (3µl, NEB, UK), plasmid DNA (10.5µg insert, 5µg recipient vector) and 
nuclease free water (up to 50µl, Thermo Scientific, UK) and incubated at 370C for 3 hours. 
Digested plasmids were then run on agarose gel (1%, 5µl of each sample) to confirm the size 
of the products. All the remaining digested product of the donor plasmid was then run 
separately and the correct sized band was excised. The excised band was then used to 
extract the DNA (Qiagen gel extraction kit, USA) and 5µl of it was run on gel along with 5µl of 
the recipient vector. The gel was used to calculate the concentrations of the insert and the 
vector and a ligation reaction was prepared accordingly. Vector DNA (50ng), insert DNA 
(calculated for 1:3 ratio), T4 ligase buffer (2µl, Thermo Scientific, UK), T4 ligase (0.2µl, 
Thermo Scientific, UK), nuclease free water (up to 20µl, Thermo Scientific, UK) was used to 
prepare the ligation reaction and a control reaction without the insert was also prepared 
(Table 2.12). Reactions were then left overnight at 40C.  
 The next day, transformation reaction was prepared as described previously and 
colonies were collected after 24 hrs. The colonies were grown in 5ml of LB media overnight 
and the DNA was extracted (MoBio mini prep kit, USA) and digested to check for the correct 
insert as described previously. The positive colony or colonies were sent to sequencing 
(Source Biosciences, Cambridge, UK) and grown further to obtain high quality plasmid DNA 
with high concentration (Qiagen midi prep kit, USA) 
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2.6 Western Blotting 
2.6.1 Solutions and reagents 
• 10X Running buffer: 
o 0.25M Tris (Sigma, Germany) 
o 1.92M Glycine (Sigma, Germany) 
o dH2O to 1L 
• 1X Running buffer: 
o 100ml 10X running buffer 
o 5ml 20% SDS (Fisher Scientific, UK) 
o dH2O to 1L 
• 10X Transfer buffer: 
o 0.25M Tris  
o 1.92M Glycine  
• 1X Transfer buffer: 
o 100ml 10X transfer buffer 
o 5ml 20% SDS 
o 200ml methanol (Fisher Scientific, UK) 
o H2O up to 1L 
• 30% Acrylamide (Severn Biotech, UK) 
• TEMED (Fisher Scientific, UK) 
• 10% APS: 
o 1g APS (Sigma, Germany) 
o dH2O to 10ml
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• PBS-Tween 
o 1X PBS (tablets, Fisher Scientific, UK) 
o 0.1% Tween 20 (Fisher Scientific, UK) 
o dH2O to 1L 
• SDS gel buffer for running gel: 
o 1.5M Tris-HCl (pH 8.8)  
o 0.4% SDS 
o dH2O to 500ml 
• Stacking gel buffer 
o 0.5M Tris-HCl (pH 6.5) 
o 0.4% SDS 
o H2O to 100ml 
• 10% Protein gel 
o 2.5ml SDS gel buffer for running gel 
o 3.3ml 30% Acrylamide stock 
o 4.2ml H2O 
o 100µl 10% APS 
o 10µl TEMED 
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2.6.2 SDS-PAGE gel electrophoresis, transfer onto membrane and 
visualization 
All western blot protocols were performed with 10% protein gels (except for 
sumoylation assay) and assembled in BioRad Mini-PROTEAN Electrophoresis System. After 
loading, gels were run for 2 hrs in 1X running buffer (constant 130V) then transferred onto 
the nitrocellulose membrane (GE, USA) (constant 200mA) for 2hrs in 1X transfer buffer. The 
membrane was blocked overnight with 5% milk in PBS-Tween at 40C (shaking) and the 
appropriate primary antibody (diluted in 3% milk in PBA-Tween) was applied for an hour at 
room temperature the next day (see table 2.7 for antibody dilutions). Fluorescently labelled 
secondary antibodies (LI-COR, US) were applied (1:5000) in 1% milk in PBS-Tween for an 
hour at room temperature. The membrane was visualised by using the LI-COR Odyssey 
imaging system.  
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2.7 In-vitro sumoylation assay 
2.7.1 Solutions and reagents 
• 1M Tris-HCl pH 8 
o 121.1g Tris base (Sigma, Germany) 
o Adjust pH with concentrated HCl 
o H2O up to 1L 
• 5M NaCl 
o 292g NaCl (Sigma, Germany) 
o H2O up to 1L 
• 10% NP-40 
o 1g of 100% NP-40 (Roche, Germany) 
o H2O up to 10ml 
• 1M PMSF 
o 17.42g PMSF (Fisher Scientific, UK) 
o DMSO up to 100ml 
• CLAP 
o Chymostatin at 1mM (Sigma, Germany) 
o Leupeptin at 2 mM (Sigma, Germany) 
o Antipain at 80 μM (Sigma, Germany) 
o Pepstatin A at 1.5 mM (Sigma, Germany) 
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• Lysis buffer 
o 5ml 1M Tris-HCl pH 8 
o 8ml 5M NaCl 
o 10ml 10% NP-40 
o 5ml 10% NaDeox 
o 200μl 1M PMSF 
o 100μl CLAP 
o H2O up to 100ml 
• Lysozyme 
o 0.2g Lysozyme (Sigma, Germany) 
o H2O up to 10ml 
• Coomassie blue stain 
o 0.1% Coomassie Brilliant Blue R-250,  
o 50% methanol 
o 10% glacial acetic acid 
• De-stain 
o 40% methanol  









2.7.2 Protein expression and purification from bacteria 
GST tagged plasmids were transformed into E.Coli Rosetta strain and single colonies 
were picked to grow in 10ml of LB overnight with the appropriate antibiotic at 370C. The 
next day a 1:100 dilution of the culture was grown in a total 300ml until an OD of 0.7 - 0.9 
and the cells were induced with IPTG (1:1000 from 1M stock, Fisher Scientific) at 180C 
overnight (shaking). The next day cell pellets were collected (4000g for 20min) and each 
pellet was resuspended in the lysis buffer and 1ml of lysozyme. After 30min incubation on 
ice, the samples were sonicated at full power at least 3 times (30sec ON, 30sec OFF). 
Sonicated material was transferred into 2ml Eppendorf tubes and centrifuged for 10min at 
14000rpm. The supernatant was collected into a new tube. Glutathine beads (Sigma, 
Germany; 420μl for each sample) were centrifuged (500g for 5min) and washed with 1ml of 
lysis buffer. The beads were resuspended with the cell lysate and incubated at 40C for an 
hour (rotating). The tubes were then centrifuged (500g for 5min) and washed with the lysis 
buffer for 3 times. Beads were then resuspended in 100μl elution buffer (10mM Tris-HCL 
pH7.4, 150mM NaCl, reduced glutathione, dH2O) and incubated at 40C for 30min (rotating). 
The samples were then centrifuged (500g for 5min) and a second elution was performed. 
After the second elution, 30μl of the samples were mixed with 1X sample buffer and run on 
SDS-PAGE gel, stained with the Coomassie blue dye and de-stained.  
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2.7.3 In-vitro sumoylation reaction 
In-vitro sumoylation reaction was performed by using the corresponding kit from 
Enzo Life Sciences, USA. For each sample three positive reactions were prepared for each 
SUMO protein (SUMO1, 2 and 3) as well as a negative reaction without ATP. RanGAP1 was 
used as a control as it gets sumoylated by all SUMO isoforms. A negative reaction for 
RanGAP1 without ATP was also prepared. The reactions were incubated at 370C for 1hr and 
20μl of 3X sample buffer was added to all reactions after. All samples were incubated at 950C 
for 5min and loaded onto the 12% SDS-PAGE gel for separation. The proteins were then 
transferred onto a PVDF membrane (as described before) and blocked with 1% BSA in PBS-
Tween for an hour at room temperature. The membrane was then washed for 10min (3 
times) in PBS-Tween and anti-SUMO1 anti-SUMO 2/3 and antibodies (provided with the kit) 
were added (1:1000 in 1%BSA in PBS-Tween) for overnight incubation at 40C. After the 
antibody incubation, the membrane was washed in PBS-Tween for 10min (3 times). 
Secondary anti-rabbit IgG (HRP linked) antibody (Abcam, UK) was applied in 1% BSA in PBS-
Tween (1:2000) for 1h at room temperature and the membrane was washed with PBS-
Tween for 10min (6 times). ECL detection reagent (Fisher Scientific, UK) was prepared and 
applied. The 5min exposure signal was detected on X-ray film (GE, USA).  
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2.8 Proximity ligation assay 
Duolink® (Sigma, Germany) was used for the proximity ligation assay. Cells were 
grown, fixed and blocked on cover slips and primary antibodies were applied as described in 
immunofluorescence section. Cover slips were then washed with PBS for 5min (2 times). PLA 
probes (provided with the kit) were diluted as described (1:5) and 80µl were applied on each 
cover slip. Samples were incubated for 1h at 370C and washed with 1X wash buffer A 
(provided with the kit) for 5min (2 times). The ligation stock (1:5) and ligase (1:40) mix were 
diluted as instructed and applied on the cover slips. After 1h incubation at 370C, 1X wash 
buffer A was applied for 2min (2 times). Amplification stock (1:5) and the Polymerase (1:80) 
were diluted as instructed and applied on cover slips. After a 100min incubation at 370C, 
samples were washed in 1X wash buffer B for 10min (2 times) and 0.01X wash buffer B for 
1min. Mounting medium (Vectashield) with DAPI was applied and samples were prepared 
for imaging.  
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2.9 Fluorescence microscopy and analysis 
All images presented in this report were taken using the Nikon Eclipse Ti-E inverted 
microscope system. For every image, Z stacks (0.300 μm steps, approx. 20 stacks for each 
image) captured the signal and the stacks were projected (maximum intensity projection) to 
get the whole signal for analyses and presentation. For single cell analyses, 100X objective 
was used, whereas for the analysis of a group of cells, 40X objective was used. The 
fluorescence intensity analyses were conducted with the Nikon software which helped us 
measure ROI sum intensity in a chosen area or in the whole image for the desired channel. 
For single locus analysis circular ROI was defined and only the intensity on the locus was 
detected. For whole image analysis all nuclei in the image was automatically detected by the 
software and the intensity was measured. All analyses were done subtracting the 
background, where there was not any cells or fluorescence signal related to the cells. Live 
cell imaging was also performed with the same system where we maintained the cells at 
370C in Leibovitz′s L-15 Medium (Gibco). 
The statistical analyses were done using the Mann-Whitney U test as Gaussian 
distribution was not expected. For PLA analysis, Chi-Square test was used. P values were 
represented as follows: ns (P > 0.05), * (P ≤ 0.05), ** (P ≤ 0.01), *** (P ≤ 0.001), **** (P ≤ 
0.0001). 
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2.10 Preperation of competent E.Coli cells 
2.10.1 Solutions and media 
• TFB1 (pH 5.8): 
o 30Mm KAc (Fisher Scientific, UK) 
o 100mM RbCl (Fisher Scientific, UK) 
o 10mM CaCl2 (Fisher Scientific, UK) 
o 50mM MnCl2 (Fisher Scientific, UK) 
o 15% Glycerol (Fisher Scientific, UK) 
• TFB2 (pH 6.5): 
o 10mM MOPS 
o 75mM CaCl2 
o 10mM RbCl 
• LB media: 
o 10g Bacto-tryptone (Fisher Scientific, UK) 
o 5g Bacto-yeast extract (Fisher Scietific, UK) 
o 500mg NaCl (Fisher Scientific, UK) 
o Up to 1L dH2O 
• LB-Agar (1L): 
o 10g Bacto-tryptone (Fisher Scientific, UK) 
o 5g Bacto-yeast extract (Fisher Scientific, UK) 
o 10g NaCl (Fisher Scientific,UK) 
o 15g Agar per 500ml (Fisher Scientific, UK) 
• 1M MgSO4 (Fisher Scientific, UK)
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2.10.2 Preparation 
E.Coli-DH5α strain cells were plated on an antibiotic free LB-Agar plate and incubated 
overnight at 370C. A single colony from the plate was inoculated in 3ml of LB and left 
overnight at 370C (shaking). The culture was diluted 1:100 the next day and 5ml of MgSO4 
was added (total volume 250ml). It was left grown to an OD of 0.4-0.6 at 370C (shaking). The 
culture was then centrifuged at 3000rpm for 5min at 40C and the supernatant was removed. 
The pellet was resuspended in 100ml of TFB1 and incubated on ice for 5min. After 
centrifuging for 5min at 3000rpm, 40C, the supernatant was removed and the pellet was 
resuspended in 5ml of TFB2. The samples were incubated on ice for 30min and aliquoted 
into 1.5ml Eppendorf tubes (200µl). The tubes were then fresh frozen in liquid nitrogen and 
stored at -800C. 
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2.11 Other solutions 
• SOC media: 
o 2g Bacto-tryptone (Fisher Scientific, UK) 
o 0.5g Bacto-yeast extract (Fisher Scientific, UK) 
o 0.05g NaCl (Fisher Scientific, UK) 
o 2.5M KCl (Fisher Scientific, UK) 
o 10mM MgCl2 (Fisher Scientific, UK) 
o 10mM MgSO4 (Fisher Scientific, UK) 
o 20mM Glucose (Fisher Scientific, UK)   
o H2O up to 100ml  
 






3. STRUCTURE AND 
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3.1 Introduction 
Phosphorylated Repo-Man has low affinity for chromosomes and this prevents early 
binding of Repo-Man on chromosomes. In fact, it was shown that when CDK1-Cyclin B 
phosphorylation sites are mutated, Repo-Man localizes on mitotic chromatin early at 
prometaphase/metaphase (Vagnarelli et al., 2011). Aurora B phosphorylation is also 
important for regulating the binding of PP1 to Repo-Man (Qian et al., 2013). It is, in a way, a 
mechanism to make sure the Repo-Man/PP1 holoenzyme is not fully activated before 
anaphase onset. The activation of the complex at the right time is important to maintain 
sufficient H3 phosphorylation on chromosomes. Full activation of the complex is achieved 
when Repo-Man is de-phosphorylated by PP1 itself. This makes Repo-Man both a substrate 
and a targeting subunit for PP1 (Vagnarelli, 2014). All the information obtained so far about 
the regulation of Repo-Man activity indicates that the control of the complex is achieved 
through phosphorylation and de-phosphorylation of Repo-Man rather than PP1.   
 The RVTF flanking region was proven to be important with previous studies but the 
actual confirmation of the complex and how the two proteins bind to each other through 
this RVTF flanking site and how this site affects localisation and function of the complex is 
still unknown. Here we hypothesize that the RVTF flanking region is regulated via multiple 
kinases and phosphorylation of this region disrupts Repo-Man and PP1 binding, therefore 
changes the timing of Repo-Man localisation and Histone H3 phosphorylation. In this 
chapter, with the help of the crystal structure our collaborators (Peti and Page laboratories, 
Brown University, U.S) kindly provided, we identify new unique sites on Repo-Man (T394, 
S400 and S407) other than the RVTF motif by NMR crystallography and show that these sites 
are important for the complex formation and localisation by mutation analyses. Phospho-
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deficient and phospho-mimetic mutations were performed on newly identified sites along 
with previously identified CDK1-Cyclin B sites and the effect of the mutant Repo-Man was 
investigated in terms of localisation, H3T3 phosphorylation and affinity for PP1.   
We also introduce Repo-Man as a Plk1 substrate and propose a model for the 
regulation of the complex throughout cell cycle, and show a mechanism to explain how the 
cells maintain H3T3 phosphorylation at the centromeres. In addition, we show the specificity 
of Repo-Man and PP1γ by a single point mutation (R20), which abolishes the binding. Our 
findings explain Repo-Man/PP1 complex structure and regulation in detail and introduce a 
new targetable area for the complex other than the RVTF motif, which is not shared with any 
other PP1 binding subunits.  
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3.2 Results 
3.2.1 Identification of novel sites on Repo-Man 
 Repo-Man, like the majority of PP1 binding subunits, has an RVxF (RVTF in case of 
Repo-Man) motif to facilitate its binding with PP1 and this motif is conserved in different 
species. RVTF motif allows Repo-Man to recruit PP1 onto mitotic chromatin and mutating 
this domain abolishes PP1 binding completely, which also results in the abolished 
recruitment of PP1 onto mitotic chromatin (Trinkle-Mulachy et al., 2006). Furthermore, this 
mutation does not disrupt chromatin binding of Repo-Man at mitosis, which shows the 
possibility of other regulatory sites for Repo-Man localisation. Recently, the region flanking 
the RVTF motif has been shown to play an important role in the localisation and function of 
the complex. Moreover, comparison of SILAC (Stable isotope labelling of amino acids in 
culture) based pull-down experiments of mitotic versus roscovitin-treated mitotic cells, have 
shown that this complex is more stable in anaphase than in early mitosis. Initial studies have 
shown that phosphorylation at two conserved sites (T412 and T419) by CDK1-Cyclin B was 
important for the localisation of Repo-Man on chromosomes (Vagnarelli et al., 2011). 
Subsequent studies, published during the course of my PhD, have also shown the 
importance of the CDK1 phospho-sites T412 and T419 in complex regulation. In addition, 
S400 was also proposed to be important for Repo-Man localisation onto mitotic chromatin. 
By mutation analyses on all three sites, it was shown that not only T412 and T419, but also 
S400 also contribute to the regulation of the complex (Qian et al., 2015). This study also 
proposed S400 as a putative CDK1 phospho-site, however, the molecular basis for the 
regulation of the complex structure and assembly were not known. 
  87 
In order to get more insight into this aspect, we wanted to obtain a crystal structure 
of the minimal interaction domain between Repo-Man and PP1. To achieve this goal we 
established a collaboration with Professor Page and Professor Peti (Brown University, USA) 
who have previously solved several structure of PP1 complexes (Choy et al., 2014; Kelker et 
al., 2009; Ragusa et al., 2010).  
Using NMR spectroscopy and isothermal titration calorimetry (ITC) approaches, our 
collaborators identified the minimal binding region of Repo-Man to PP1γ and showed that 
this contains the previously identified sites shown to be important for the complex function 
(T412, T419 and S400) (Vagnarelli et al, 2011; Qian et al., 2015). The crystal structure 
revealed that Repo-Man stretches along a large area on PP1 surface and these sites 
represent contact points between Repo-Man and PP1.  
The structure obtained has also revealed other additional interesting features: for 
example other contact points S407 and F404 (Figure 3.2, A), which are also conserved 
(Figure 3.2, B). To have a better understanding on the function of these contact points, 
mutation analyses were undertaken. Traditionally, the experiments to assess the function of 
a mutant are conducted in the absence of the endogenous proteins since not all the 
mutations will be dominant-negative and also because we do not know if this complex acts 
as a monomer or it can multimerise. 
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Figure 3.1: Repo-Man does not dimerize. A. DT40 cells with LacO array inserted in their 
genome (Vagnarelli, 2006) were co-transfected with GFP:Laci:Repo-Man and Repo-ManTRAP 
constructs and stained with anti-SBP antibody (in red). A single Repo-Man:Laci signal in 
green was observed but a red signal could not be detected. GFP:Laci only, was used as a 
control. Scale bar 5µm. B. Quantification of the experiment in A. Graph shows the 
percentage of the cells that have both signals together (+) or just have one signal (-) in Repo-
Man:Laci and Repo-ManTRAP co-transfected cells. Images are representative of a single 
experiment. Total cell count is 100. Fluorescent microscope is used.  
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Although my experiments suggest that the complex likely acts as a monomer (Figure 
3.1), I decided to test the function of these sites in absence of the endogenous protein. In 
order to perform these experiments, I have first generated an RNAi-resistant version of the 
GFP-tagged full length Repo-Man construct (GFP:RMres2 ) (Figure 3.2, C) by site directed 
mutagenesis. The mutations were designed to change the codon but not the amino acid 
sequence so that the constructs could be expressed in an RNAi background.  
To prove that the oligo-resistant construct worked, HeLa cells were transfected with 
the GFP:RMres2 and GFP:RMwt together with control and Repo-Man siRNA oligos (Figure 3.3, 
A). GFP:RMres2 transfection was detectable in both control and treatment, whereas GFP:RMwt 
was only present in control siRNA treated cells. Moreover the localisation of the GFP:RMres2 
construct was undistinguishable from the GFP:RMwt .  
The new identified sites were then mutated to Alanine (A) and Aspartic Acid (D) on 
the oligo-resistant mutant (Res2) along with previously identified amino acids to mimic the 
phospho-deficient and phosphorylated states of the protein (Figure 3.2, D).   
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Figure 3.2: First crystal structure of Repo-Man/PP1 complex and identification of a novel 
interaction site. A. Crystal structure of a fraction of Repo-Man bound to PP1γ, showing the 
newly identified residues S400, F404, S407 as well as previously identified ones T412 and 
T419 (Provided by Peti and Page laboratories at Brown University, USA). B. Alignment 
showing the conservation of identified sites (S400 and S407 in orange; T412 and T419 in 
blue) as well as the RVTF (green) motif among species. C. Introduced oligo-resistant 
mutations (T177, L179, T180 and R181) on GFP:RMwt changed the codons but not the amino 
acids, which prevented the siRNA binding but conserved wild type phenotype. D. Mutations 
of identified sites performed on the Res2, including A and D mutations on four (S400, S407, 
T412, T419) and three (S400, T412, T419) of the sites; D mutation on two (S400, S407) of the 
sites; and A mutation on F404. 
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3.2.2 Mutations on identified sites affect Repo-Man localisation on 
chromosomes 
In order to assess the function of the new residues identified in the stability of the 
complex, HeLa cells were transfected with all the Alanine mutants, in a Repo-Man RNAi 
background. Since these mutants are phospho-deficient, the Repo-Man/PP1 complex was 
expected to be hyper-active in early mitosis (Vagnarelli et al., 2011; Qian et al., 2015). 
H3T3ph staining was used to measure the activity of the complex in comparison with the 
wild type protein. Images of both Repo-Man transfected and un-transfected cells were taken 
to show the differences of activity, and the H3T3ph staining was normalised against the un-
transfected cells on the same slide (Figure 3.4, A).  
As expected, depletion of Repo-Man causes a hyper-phosphorylation of H3T3 with a 
distribution that covers all the chromosomes instead of being restricted to the centromeric 
region. All the mutants were able to rescue reduce the H3T3 hyper-phosphorylation levels 
caused by depletion of Repo-Man and the remaining H3T3 phosphorylation on Repo-Man 
transfected cells was not significantly different than that of wild type Repo-Man (Figure 3.4, 
C), showing that the complex was indeed active.  
Also, transfected cells showed a distinct H3T3ph pattern and to address if the 
residual phosphorylation was indeed centromeric, GFP:Repo-ManFA  transfected cells were 
stained with the anti-centromeric antibody (ACA). The staining clearly showed that the 
remaining H3T3 phosphorylation overlaps with the centromeres (Figure 3.5, A).  
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Although I did not observe dramatic differences between the mutants in terms of 
activity, I observed significant differences in localisations with some mutants being localised 
on chromosomes in early mitosis and others not. To quantify these differences, Repo-Man 
signal intensity was measured on the chromosomes and the cytoplasm at 3 different circular 
points each, with an additional spot in the background. The background was subtracted and 
the average signal was calculated for chromosomes and cytoplasm. The ratio of the signal 
intensity on the chromosomes to the cytoplasm was then calculated for each individual cell. 
H3T3 phosphorylation was also calculated in a similar way: The overall signal was measured 
with a single circular ROI, covering all chromosomes, with an additional spot in the 
background that covers the same area. The background was subtracted and the signal from 
transfected cells were normalised against the average signal from the un-transfected cells.  
These experiments have shown that the 3Ares and 4Ares mutants prematurely 
localised on the chromosomes at pro-metaphase/metaphase, whereas FAres mimicked the 
localisation of the wild type protein (Figure 3.4, B). 
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Figure 3.3: Oligo resistant Repo-Man is still expressed in the presence of Repo-Man siRNA. 
Wild type (RMwt) and oligo resistant mutant (Res2) expression in HeLa cells with control and 
Repo-Man siRNA (48 hrs), showing the abolished expression of the wild type with Repo-Man 
siRNA, whereas the Res2 expression is still present. Scale bar 10µm. Images are 
representative of a single experiment.  
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Figure 3.4: Phospho-deficient mutations on newly identified sites cause pre-mature 
localisation of Repo-Man on chromosomes. A.  HeLa cells transfected with the A mutants 
and stained for H3T3ph in RNAi background, showing the pre-mature localisation of 3Ares 
and 4ARes mutants on chromosomes and wild type-like localisation of the FARes mutant. 
H3T3 phosphorylation in transfected cells is visibly less than un-transfected cells. Sacle bar 
10µm. B. Graph showing mutant and wild type Repo-Man enrichment on chromosomes. 
3ARes and 4ARes are significantly higher than the wild type and FARes. C. Graph showing the 
remaining H3T3 phosphorylation, normalised against the un-transfected cells. The 
phosphorylation does not significantly differ from that of wild type with any of the mutants. 
Images are representative of three repeats. Total cell count is 30 for each experiment. 
Fluorescent microscope is used. Mann-Whitney test is used for significance.    
  95 
 
Figure 3.5: Remaining H3T3 phosphorylation overlap with the centromeres. HeLa cells 
transfected by wild type Repo-Man were stained for H3T3ph (Red) and ACA (Green). 
Remaining H3T3 phosphorylation on the chromosomes, overlap with the centromeric 
staining, whereas the chromosome arms (Blue) are completely free of the phosphorylation. 
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3.2.3 PP1 binding is important for Repo-Man localisation on chromosomes 
Repo-Man localisation on chromosomes does not happen until anaphase onset and it 
was shown that this localisation is a dynamic event, depending on the activity of Repo-Man 
activating and inactivating proteins. So far, Aurora B activity and PP2A-B56 binding has been 
reported to be important for the regulation of Repo-Man localization on chromosomes.  By 
phosphorylating Repo-Man at S893, Aurora B prevents premature localization until the 
phosphorylation is removed by PP2A-B56 and if Aurora B is inhibited, premature localization 
of Repo-Man on chromosomes is observed (Qian et al., 2011). Also a phospho-mimetic 
mutation on S893 abolishes Repo-man localisation on chromosomes and causes H3T3 
phosphorylation to remain (Qian et al., 2011; Qian et al., 2015).  
However, the data I have obtained using several mutants I have generated indicate 
that the region flanking the RVTF motif on Repo-Man is important for the activation of the 
complex and the localisation of Repo-Man can be controlled on this region. Since we have 
shown that these amino acids are contact points within the complex, it can be hypothesised 
that PP1 pays a significant role in the regulation of chromosome targeting of Repo-Man. It is 
also known that PP1 binding is a major factor for Repo-Man localisation on chromosomes 
and a mutated RVTF motif (RAXA) abolishes the binding between Repo-Man and PP1, but 
does not affect Repo-Man binding to mitotic chromatin (Trinkle-Mulcahy et al., 2006).  
To test the contribution of these mechanisms, HeLa cells were transfected with wild 
type and 3A (S400, T412 and T419) mutants along with their non-PP1 binding versions 
(RM_RAXA and 3A_RAXA), in the presence or absence of Aurora B inhibitor (ZM447439) and 
their chromosomal localisation was analysed.  
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In the untreated cells, the 3A mutant localised on the chromosomes at early mitosis 
as expected, whereas the 3A_RAXA mutant rescued the pre-mature localisation, showing a 
wild type-like phenotype (Figure 3.6, A). In the ZM treated cells on the other hand, the pre-
mature localisation was observed with all mutants as well as the wild type protein. Repo-
Man signal intensity on the chromosomes and in the cytoplasm were measured and similar 
to the previous analyses, the ratio of signal intensity on the chromosomes over the 
cytoplasm was calculated.  Analysis of these localisations shows that there is a significant 
difference between the RM_RAXA and 3A_RAXA mutants in the untreated cells, as well as 
the wild type and the RM_RAXA mutant in the treated cells (Figure 3.6, B and C). These 
datasets clearly indicate that both PP1 and Aurora B contribute to the localisation of Repo-
Man to chromosomes. 
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Figure 3.6: PP1 binding is important for Repo-Man localisation on chromosomes. A. HeLa 
cells transfected with wild type Repo-Man and the 3A mutant along with RM_RAXA and 
3A_RAXA in the presence or absence of the Aurora B inhibitor ZM447439. Cells treated with 
20µM of inhibitor for 3 hrs. Scale bar 10µm. B. Graph showing Repo-Man enrichment on 
chromosomes on untreated cells. 3A is significantly more on the chromosomes than the wild 
type, whereas 3A_RAXA is significantly less on the chromosomes when compared to 3A. C. 
Graph showing Repo-Man enrichment on ZM447439 treated cells. There is no significant 
difference between the mutants and the wild type protein except for RM_RAXA, which is 
significantly less accumulated on chromosomes. Mann-Whitney test was used for statistical 
analysis. Images are representative of three repeats. Total cell count is 30 for each 
experiment. Fluorescent microscope is used. 
    
  99 
3.2.4 Phosphorylation of the newly identifies Repo-Man SLIM motif 
regulates PP1 binding. 
 After establishing that PP1 is important for Repo-Man localisation on chromosomes, 
we wanted to directly prove that phosphorylation of these residues were indeed important 
for PP1 binding, independently of RVTF motif.  For this purpose we have mutated the newly 
identified sites to Aspartic Acid (3D) and cloned the Laci sequence in the construct to 
generate the GFP:Laci:RM3D. Then we have used a tethering system with chicken DT40 cell 
lines carrying a LacO array inserted in their genome (Vagnarelli et al., 2006) (Figure 3.7, A) 
and co-transfected these cells with wild type and mutant Repo-Man along with RFP tagged 
PP1γ. The transfected cells showed a single spot of wild type or mutant Repo-Man on the 
chromosomes, where the LacO/Laci interaction occurs, and a red spot was observed on the 
same spot, if PP1γ was recruited as well. As expected, wild type Repo-Man recruited PP1γ on 
the same spot, whereas the 3D mutant abolished the binding and did not have any PP1γ 
signal (Figure 3.7, B). The non-PP1 binding RAXA mutant was used as a control, which also 
did not recruit PP1. This shows that the complex can be inactivated through the RVTF 
flanking region.  
 To see if the phospho-mimetic mutants differ from the wild type protein in terms of 
localisation and H3T3 phosphorylation, HeLa cells were transfected with 3DRes and 4DRes 
mutants in RNAi background (Figure 3.8, A). The localisation of the phospho-mimetic 
mutants showed a dispersed phenotype, which , as expected, did not differ from the wild 
type, and the remaining H3T3 phosphorylation was not significantly different from that of 
wild type in prometaphase cells (Figure 3.8, B and C). 
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Figure 3.7: Phospho-mimetic mutations on Repo-Man, inactivate the complex by 
abolishing PP1 binding. A. The tethering system used to assess the formation of the complex 
in vivo. DT40 cells containing a LacO array inserted at a single locus were co-transfected with 
Laci:GFP:Repo-Manwt or mutant forms and RFP tagged PP1γ. Using the LacO/Laci interaction, 
a single Repo-Man-enriched spot was obtained and recruitment of PP1γ was measured. 
Scale bar 5µm. B. PP1γ recruitment on wild type Repo-Man and the non PP1 binding RAXA 
mutant were used as controls. PP1γ accumulation at the LacO array is significantly reduced 
with the phospho-mimetic 3D mutant. Mann-Whitney test was used for statistical analysis. 
Images are representative of three repeats. Total cell count is 50 for each experiment. 
Fluorescent microscope is used.    
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Figure 3.8: Phospho-mimetic mutants do not affect localisation or H3T3 phosphorylation. 
A. Hela cells transfected with the 3D and 4D mutants as well as the wild type in RNAi 
background (48 hrs), and stained for H3T3ph. Localisation of the mutants are not different 
than the wild type. Un-transfected cells were used as a control. Scale bar 10µm. B. Graph 
showing Repo-Man enrichment on chromosomes. There is no significance between the wild 
type and the mutants. C. Quantification of the remaining H3T3 phosphorylation, normalised 
against the un-transfected cells. There is no significant difference between wild type and 
mutant proteins. Mann-Whitney test was used for statistical analysis. Images are 
representative of three repeats. Total cell count is 30 for each experiment. Fluorescent 
microscope is used. 
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3.2.5 Phosphorylation of the RVTF motif abolishes the binding between 
Repo-Man and PP1 
 We have so far shown that the RVTF motif is responsible for Repo-Man/PP1 binding 
and the localisation of Repo-Man onto mitotic chromatin along with Aurora B. We have also 
reported the regulation of a unique region flanking the RVTF motif by phosphorylation in 
order to keep the complex inactive and off the chromosomes. All these analyses clearly show 
the importance of both the RVTF motif and the flanking region in complex formation and 
localisation. In addition, proteomic screenings have also identified previously that T394 of 
the RVTF motif is also getting phosphorylated (Dephoure et al., 2008; Nousiainen et al., 
2006), but the kinase responsible for this phosphorylation remained elusive.  
 By using in-vitro phosphorylation assay, coupled with NMR spectroscopy and mass 
spectrometry, our collaborators (Peti and Page laboratories, Brown University, USA) 
identified Aurora B as the kinase responsible for the phosphorylation of T394 in the RVTF 
motif. To see if this phosphorylation affects PP1 binding, I have generated a phosphor-
mimetic mutant of this site (RVDF) and performed a recruitment experiment. Using the 
Laci/LacO tethering system, I have recruited the wild type PP1 on wild type Repo-Man but 
not with the RVDF mutant (Figure 3.9, A). The mutation on this Aurora B site, completely 
abolished the recruitment of PP1 like the RAXA mutant, which was used as a control. 
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Figure 3.9: Phosphorylation of T394 by Aurora B abolishes the binding between Repo-Man 
and PP1. A. Chicken DT40 cells were transfected with wild type Repo-Man and RVDF mutant 
as well as the RAXA mutant, using the Laci/LacO tethering system. Scale bar 5µm. B. Analysis 
of the experiment in A. PP1 signal intensity at the LacO array was measured. Data was 
analysed using Mann-Whitney test. A significant decrease is observed with the RVDF mutant. 
Statistics show the comparison with the wild type protein. Images are representative of 
three repeats. Total cell count is 50 for each experiment. Fluorescent microscope is used. 
Mann-Whitney test is used for significance.    
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3.2.6 Is Plk1 involved in the local regulation of Repo-Man/PP1 complex in 
early mitosis? 
 I have so far shown that phosphorylation of the newly identified SLIM on Repo-Man 
is important in regulating the complex at mitosis, therefore it also important to identify how 
this regulation occurs and which kinases are involved in the process. As mentioned earlier, it 
is already known that two of the sites in this region (T412 and T419) are phosphorylated by 
CDK1-CyclinB at early mitosis (demonstrated by in vitro phosphorylation experiments)  
(Vagnarelli et al, 2011). No experiments have been conducted on the other sites.  We have 
therefore run a database search on this region to identified kinases that might be involved in 
regulating Repo-Man. Our database research (GPS-Polo) suggested that Plk1 has potential 
priming (T412 and T419) and phosphorylation (S400 and S407) sites on this region (Figure 
3.10, B). Moreover, in a phospho-proteomic screening for PLK1-dependent phosphorylations 
in mitosis by Santamaria et al. (2010) (Figure 3.10, A), these sites were also identified.  
To observe the effect of Plk1 on Repo-Man localisation, the predicted 
phosphorylation sites of Plk1 (S400 and S407) were mutated to Alanine on the oligo resistant 
construct (2Ares) and HeLa cells were transfected with either this mutant and or wild type 
Repo-Man in an RNAi background. The cells were also stained for H3T3ph. The results of 
these experiments show that the 2Ares mutant does not affect the localisation. Transfected 
cells showed a dispersed phenotype like the wild type protein (Figure 3.10, C) and do not 
accumulate on the chromosomes. Nevertheless, these cells showed a difference in terms of 
the H3T3 phosphorylation. Cells transfected with the 2Ares mutant did not show an 
accumulation of the remaining H3T3 phosphorylation at the centromeres. Instead, they 
showed a dispersed although reduced H3T3 phosphorylation (Figure 3.10, D, E). 
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To analyse this aspect in more detail, HeLa cells stably expressing GFP:CENP-A were 
transfected with the 2Ares mutant and stained for H3T3ph in an RNAi background. The 
remaining H3T3 phosphorylation at the CENP-A and distal regions were measured and 
compared to the wild type. The results showed that the remaining phosphorylation with wild 
type Repo-Man transfected cells were mostly on the centromeres, whereas with the 2Ares 
mutant transfected cells it was dispersed and not accumulated at the centromeres (Figure 
3.11, A, B).  Total H3T3 phosphorylation was again observed to be less with the 2ARes 
mutant (Figure 3.11, C).  
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Figure 3.10: Phospho-deficient mutations on Plk1 sites do not affect localisation but makes 
a difference with H3T3 phosphorylation. A. Predicted Plk1 phosphorylation sites as shown 
in Santamaria et al. (2010). B. Predicted Plk1 binding and phosphorylation sites on GPS Polo 
database. T412 and T419 are shown as phospho-binding sites, whereas S400 and S407 are 
shown as phosphorylation sites. C. HeLa cells transfected with wild type (RMwt) and mutant 
(2A) Repo-Man in RNAi background (48 hrs). The 2A mutant shows the same localisation as 
the wild type protein. Scale bar 10µm. D. Quantification of Repo-man localisation on 
chromosomes. No significant difference between wild type and mutant. E. Graph showing 
the total H3T3ph. The phosphorylation is significantly lower with the 2A mutant. Mann-
Whitney test was used for statistical analysis. Images are representative of three repeats. 
Total cell count is 30 for each experiment. Fluorescent microscope is used. 
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Figure 3.11: Plk1 phsophorylates Repo-Man and maintains H3T3 phosphorylation at the 
centromeres. A. HeLa cells stably expressing GFP:CENP-A, were transfected with oligo 
resistant wild type (Res2) and mutant (2ARes) Repo-Man in RNAi background (48 hrs), 
incubated with 75mM KCl before fixation and stained for  H3T3ph. B. Graph showing the 
H3T3ph enrichment at the centromeres for wild type and mutant Repo-Man (n=15). 
Remaining H3T3ph is significantly higher at the centromeres with the wild type protein. C. 
Total H3T3ph measured all over the chromosomes with wild type and mutant Repo-Man, 
showing a significantly less phosphorylation with the 2ARes mutant. Images are 
representative of three repeats. Total cell count is 30 for each experiment. Fluorescent 
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3.2.7 Repo-Man specifically binds to PP1γ and not PP1α 
 It was already shown that Repo-Man successfully recruits PP1γ with high affinity and 
it also binds to PP1β with a lower affinity but not to PP1α (Booth et al., 2014; Trinkle-
Mulcahy et al., 2006; Vagnarelli et al., 2011). However, the question about isoform 
specificity of the targeting subunits is still very much an open question. Based on the amino 
acid sequence of the different PP1 isoforms (PP1α and PP1γ),  it would be expected that the 
15 amino acids C-terminal domain is involved in conferring specificity since is the most 
diverse region among the different isoforms (Figure 3.12).  Having generated the crystal 
structure of PP1 together with the interacting domain of Repo-Man we can start looking into 
this question: How does Repo-Man differentiate between PP1γ and PP1α? 
The N terminus on the other hand, has 4 amino acid differences.  Our collaborators 
(Peti and Page Laboratories, Brown University) have deleted the 15 amino acids at the C 
terminus and showed that this region does not have an effect on the binding affinity. 
However, looking in details at the contact point between the two subunits, only the Arg20 in 
PP1γ is in close proximity to Repo-Man. This Arg is a unique difference among a series of 
conserved residues. Interestingly, it was previously shown that a mutation of this site had an 
effect on PP1γ localisation throughout the cell cycle (Lesage et al., 2005), however no 
molecular clues were available to understand its specific function. 
We have therefore mutated the Arg20 residue on the N terminus PP1γ to Gly.  This 
way, we have transformed PP1γ into the exact sequence of PP1α. Our results confirm that 
this mutant changes localisation throughout the cell cycle. HeLa cells were transfected with 
both wild type and mutant PP1γ and the cellular distribution of the construct was analysed 
during the cell cycle.  
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In early mitosis the mutant showed a dispersed localisation (Figure 3.12, A) and in 
anaphase, it was not recruited to the chromosomes. Since several studies have shown that 
Repo-Man is the targeting subunit that is responsible for the recruitment of PP1 to the 
chromosomes in anaphase (hence the name) we hypothesised that this mutation could 
indeed disrupt the binding between the targeting and cathalytic subunit.  
In order to prove this, I have used the Laci/LacO tethering system. Chicken DT40 cells 
were transfected with wild type and RAXA mutant Repo-Man along with wild type and 
mutant PP1γ. Wild type Repo-Man successfully recruited wild type PP1γ, whereas mutant 
PP1γ was not recruited at all or recruited less than the wild type. RAXA mutant was used as a 
control, since we have already established that it does not bind to PP1 (Figure 3.13, C). 
Since these residues involved in the isoform selection are highly conserved in another 
PP1 targeting subunit (Ki-67), we tested if the behaviour was the same also for Ki-67. 
Chicken DT40 cells and the Laci/LacO system were used for this purpose. The cells were 
transfected with GFP:Laci, as a control, and GFP:Laci:Ki67 constructs as well as wild type and 
mutant RFP tagged PP1γ. A single GFP or Ki67 locus was generated and PP1γ recruitment on 
both was calculated. Results show that the R20 on PP1γ is important also for Ki67 binding 
and changes the behaviour completely. Wild type Ki67 successfully recruited wild type PP1γ, 
whereas mutant PP1γ was not recruited at all Figure 3.14,A). These experiments altogether 
represent the first demonstration of the molecular basis for the isoform specificity between 
a targeting subunit and PP1. 
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Figure 3.12: Alignment of PP1γ and PP1α protein sequences. Alignment of two PP1 
isoforms on T-Coffee online alignment tool. PP1α is represented with PP1a, PP1γ is 
represented with PP1g and both sequences are the human isoforms. Differences on the C -
terminal area are more noticeable than the differences on the N-terminal area, where we 
expected to see a difference in Repo-Man binding. 
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Figure 3.13: R20Q mutation on PP1γ abolishes the localisation and prevents Repo-Man 
from recruiting PP1. A. HeLa cells transfected with wild type (upper plane) and mutant PP1γ 
(lower plane) at different stages of the cell cycle. Mutant PP1 changes the localisation 
completely (scale bar 10µm). B. Quantification of PP1γ on chromosomes. R20 mutant is 
significantly less recruited. C. Chicken DT40 cells transfected with wild type Repo-Man along 
with wild type and mutant PP1γ. Repo-Man cannot recruit mutant PP1γ. RAXA mutant was 
used as a control (scale bar 5µm). D. Quantification of PP1γ recruitment on single Repo-Man 
focus, showing the significant decrease with PP1γ mutant. Mann-Whitney test was used for 
statistical analysis. Images are representative of three repeats. Total cell count is 30 (for 
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Figure 3.14: Ki67 does not recruit mutant PP1γ. A. Fluorescent images of DT40 cells 
transfected with GFP:Laci only and GFP:Laci:Ki67 as well as RFP tagged wild type and mutant 
PP1γ. Mutant PP1γ is not recruited by wild type Ki67. Recruitment on GFP alone was used as 
a control. Scale bar 5µm. B. Quantification of the experiment in A. Mutant PP1γ is 
significantly less recruited by Ki67. Mann-Whitney test was used for statistical analysis. 
Images are representative of three repeats. Total cell count is 50 for each experiment. 
Fluorescent microscope is used.    
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3.3 Discussion 
 Repo-Man is a multifunctional PP1 targeting subunit that controls  chromosome 
organisation and dynamics as well as NE dynamics during mitosis. In this chapter, we focused 
on identifying the molecular basis regulating the complex formation in order to better 
understand how the complex is regulated throughout mitosis. It was already known that, like 
most PP1 binding subunits, Repo-Man binds to PP1 through an RVxF motif (RVTF). This motif 
is highly conserved and shared by many targeting subunits and therefore it does not 
represent a useful Protein-Protein Interaction (PPI) surface that will be amenable to target 
for clinical purposes. However, previous studies had suggested that other regions outside 
the RVxF could have been important for the complex assembly and stability. 
The first studies on the RVTF flanking region showed that T412 and T419 residues are 
phosphorylated by CDK1 at the beginning of mitosis and that this phosphorylation is 
important in localising Repo-Man onto chromosomes at mitotic exit (Vagnarelli et al., 2011). 
Here we have identified S400, F404 and S407 as possible regulatory regions with the help of 
our collaborators. With NMR crystallography, the minimal binding region of Repo-Man to 
PP1 was identified and these residues were in critical positions to stabilise the binding. 
Mutation analyses have shown that phospho-deficient mutations to Alanine (3A and 4A) on 
this region localise pre-maturely on chromosomes: this suggests that phosphorylations on 
these sites keep Repo-Man from localising onto mitotic chromatin earlier than it should. The 
phospho-mimetic mutations to Aspartic Acid (3D and 4D) showed a wild type-like phenotype 
but also a decreased affinity for PP1 even in interphase. Taken together these data strongly
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 indicate that phospho-switches of the SLIM motif are essential for the complex formation 
and stability. 
Repo-Man localisation onto chromosomes at mitosis has been previously 
investigated by the Bollen lab. In these studies, Repo-Man phosphorylation at S893 by 
Aurora B was reported to be important for its localisation (Qian et al., 2011). Our results 
show that the contribution of Aurora B phosphorylation at S893 is significant but PP1 binding 
is also necessary for Repo-Man localisation onto chromosomes. In normal cells, the RAXA 
mutant rescued the pre-mature localisation of the 3A mutant. Similarly, in cells where 
Aurora B is inhibited  (by ZM447439 treatment), even though wild type Repo-Man was 
localised on chromosomes as well as the 3A, the RAXA mutant showed a significant decrease 
in its chromosome localisation.  The fact that RAXA mutant decreases but cannot rescue the 
localisation completely, tells us that Aurora B phosphorylation is significantly important but 
PP1 binding is priority.  
However, we have now also discovered that AuroraB phosphorylates a residue within 
the RVxF and that this phosphorylation diminished PP1 binding. In light of this, Aurora B 
inhibition is affecting both targeting systems: the C-terminus histone binding domain and 
PP1 binding.   
Our results clearly showed that the region flanking the RVTF motif is important in 
regulation of the complex. We already know CDK1 is responsible for phosphorylation of T412 
and T419 and in addition, T394 (T in RVTF motif) is phosphorylated by Aurora B (Kumar et al., 
2016). This was demonstrated via in-vitro phosphorylation coupled with NMR spectroscopy 
and mass spectrometry. Our in silico analyses revealed that the remaining two residues 
(S400 and S407) could be phosphorylated by Plk1.  
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The Phospho-deficient mutants on Plk1 sites have also an interesting phenotype in 
early mitosis: they abolish the centromeric accumulation of the remaining H3T3 
phosphorylation; this suggests that Plk1 phosphorylation on these sites keep Repo-Man/PP1 
complex inactive at the centromeres but not at the chromosome arms.  
We can then imagine that different kinases contribute to the full inactivation of the 
complex in mitosis (CDK1, AuroraB, Plk1). A total inactivation would results in a 
hyperphosporylation of H3T3 with a distribution all over the chromosomes (as seen in the 
case of Repo-Man RNAi). However, in normal mitosis, the H3T3ph is retained at centromere 
indicating that somehow Repo-Man cannot de-phosphorylate these centromeric residues.  
We already know that the centromeric region is where Aurora B is localised and active PLK1 
is localised.  Therefore, we hypothesise that there is a gradient of active kinases at the 
centromere that make sure that all the sites that contribute to the stability of the complex 
are phosphorylated: this will produce a local full inactivation of the complex (Figure 3.15, C).   
Still, the overall H3T3 phosphorylation was lower with the Plk1 mutant (2A), proving that the 
complex is more active than the wild type.  
 We have also showed the mechanism of how Repo-Man recognises PP1γ selectively. 
With the help from our collaborators, we have identified that the selection occurs through 
the N terminal region of PP1. The R20 residue was shown to have an effect on PP1 
localisation previously (Lesage et al., 2005), but the crystal structure that we have provided 
also shows the R20 residue in close proximity of Repo-Man when bound to PP1γ (Kumar et 
al., 2016). By mutating this residue to Gly to mimic PP1α, we abolished the binding of Repo-
Man to PP1 and showed that Repo-Man’s affinity to PP1γ occurs through the R20 residue. 
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Figure 3.15: Working model. A. Showing the putative Plk1 phospho and docking sites on a 
linear representation. The sites look far away from each other in this representation. B.  
Crystal structure of Repo-Man bound to PP1, showing the real representation of the Plk1 
sites. The docking and phospho sites are exactly opposite each other. C. Our hypothesis on 
the regulation of H3T3 phosphorylation. The kinase gradient on the chromosomes is lower at 
the arms and higher at the centromere, keeping the complex inactive at the centromere and 
keeping the H3T3 phosphorylated. 






4. REPO-MAN REGULATES 
LAMIN A/C DE-
PHOSPHORYLATION  
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4.1 Introduction 
Repo-Man has been shown to interact with nuclear envelope (NE) proteins like 
Nup153 and Importinβ and help nuclear envelope reassembly (Vagnarelli et al., 2011). It was 
also shown that Repo-Man knockdown causes abnormal NE. Here we show that it also 
interacts with Lamin A/C and regulates its de-phosphorylation for a successful NE 
reassembly and it may depend on the sumoylation of Repo-Man.  
The mitotic sites S22 (N terminus) and S392 (C terminus) have been shown to 
promote disassembly of nuclear lamina when phosphorylated (Heald and McKeen, 1990). It 
is well-known that phosphorylation of lamins occur continuously throughout the cell cycle, 
during both interphase and mitosis. So far, functions of these phosphorylations were 
explained in terms of nuclear targeting or assembly/disassembly of lamins (Luscher et al., 
1991; Ottaviano and Gerace, 1985; Rzepecki et al., 2002) and knowing that the absence of 
Repo-Man causes abnormal lamina and Lamin A/C localisation, gave us a hint that Lamin A/C 
and Repo-Man may be interacting.  
Furthermore, it has been reported recently that the re-assembly of Lamin A/C after 
mitosis depends on its SUMO-interacting motif (SIM). This motif is essential for Lamin A/C 
recruitment on the chromosomes but most importantly, it is necessary for de-
phosphorylation of the S22 at the end of mitosis (Moriuchi et al., 2016). Here we 
hypothesize that Repo-Man is involved in de-phosphorylation of Lamin A/C. In this chapter 
we show that Repo-Man and Lamin A/C interact and this interaction may be through 
sumoylation, although we could not detect Repo-Man sumoylation in vitro. In addition, we 
prove that absence of Repo-Man affects Lamin A/C phosphorylation levels at interphase.  
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4.2 Results  
4.2.1 Repo-Man knockdown causes abnormal nuclear lamina that lack 
stiffness. 
 Repo-Man effect on the nuclear envelope reassembly and nuclear lamina and its 
interaction with some nuclear lamina proteins has already been established. Repo-Man 
directly binds to Importinβ and recruits it to the chromatin at anaphase to initiate nuclear 
lamina re-assembly. Furthermore, depletion of Repo-Man causes dramatic changes in the 
nuclear lamina; this could be a consequence of insufficient loading of Importinβ around the 
chromatin at anaphase. It was also reported that HP1 localisation (Vagnarelli et al., 2011) 
and, more recently heterochromatin at the nuclear periphery are affected by Repo-Man 
depletion as well (DeCastro et al, 2016 in press). 
To investigate the effect of Repo-Man on the nuclear lamina in more details, we have 
performed Repo-Man knock-down experiments in HeLa cells and stained for Lamin A/C. As 
previously reported, upon Repo-Man RNAi, nuclei have an irregular shape compared to the 
Control RNAi nuclei (Figure 4.1, A_ No KCl). This phenotype can be quantified by using the 
“circularity” descriptor within the analyses software package of AS-Nikon (Figure 4.1, B).  
This phenotype could be caused by different problems both on the Lamina per se or in the 
underlying chromatin. However, because both these structure have been shown to 
contribute to provide structure and rigidity to the nuclear lamina, experiments were carried 
out to test if Repo-Man depleted cells present lack of rigidity in their NE. After RNAi, the cells 
were incubated in hypotonic solution (75mM KCl) or PBS and stained for total Lamin A/C 
(Figure 4.1, A) and then the nuclei were analysed for circularity. 
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  As expected, Control nuclei become more circular after KCl treatment but, more 
importantly, the hypotonic treatment rescued this abnormal nuclear morphology of Repo-
Man RNAi treated cells to the point that in these conditions, they are not distinguishable 
from the control cells (Figure 4.1, A and B). In addition, total Lamin A/C levels are also shown 
to emphasise that Repo-Man knockdown does not change total Lamin A/C levels in the cell. 
Our results not only prove the consequences of Repo-Man knock-down once again, 
but also show that this defect in Lamin A/C causes the formation of a NE that lacks stiffness. 
Therefore the multiple invaginations observed in the Lamina in the absence of Repo-Man are 
the consequence of lack of rigidity. 
As mentioned before, Lamin A/C is highly phosphorylated at mitosis and this 
phosphorylation triggers its dissociation from the nuclear lamina, but a low level of 
phosphorylation at interphase is also observed (Heald and McKeen, 1990; Kochin et al., 
2014). Similarly, reversal of this phosphorylation towards the end of mitosis triggers re-
incorporation of Lamin A/C to the nuclear lamina but there is no information on the 
phosphatase responsible for this de-phosphorylation.  These data indicate that the Lamina 
structure is affected by phosphorylation.  
 Since Repo-Man is a phosphatase that is loaded on the chromatin during anaphase 
and its absence causes defects in Lamin A/C re-assembly, potentially it could represent a 
plausible candidate for Lamin A/C de-phosphorylation.   
Based on this, I set up to answer the question: “Does Repo-Man affect de-
phosphorylation of Lamin A/C?”   
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Figure 4.1: Repo-Man knock-down affects cell circularity through Lamin A/C. A. HeLa cells 
transfected with Repo-Man (RMsi) and control siRNA (48h) were incubated with or without 
KCl (75mM) for 20min and stained for total Lamin A/C (in red) and DAPI (in blue). Cells with 
“no KCl” were incubated in PBS for equal amount of time. The images clearly show the 
abnormal lamina morphology in the Repo-Man siRNA transfected cells and the rescued 
phenotype after KCl treatment. Scale bar 10µm. B. Quantification of the experiment in A, 
calculated on Image J, showing the significant difference before and after the hypotonic 
treatment as well as between control and Repo-Man siRNA. KCl treatment abolished the 
significant difference as shown on the graph (n=35). Mann-Whitney test is used for statistics. 
Images are representative of a single experiment. C. Total Lamin A/C enrichment is shown to 
prove that Repo-Man knockdown does not affect total Lamin A/C levels. 
C. 
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4.2.2 Repo-Man knockdown affects Lamin A/C phosphorylation. 
Using a commercial antibody against Lamin AS22Ph, I have analysed the dynamic of 
Lamin A phosphorylation during mitosis (Figure 4.2). As reported before, phospho-Lamin A/C 
is at low levels at interphase but increases dramatically during mitosis until cytokinesis. I 
could reproduce the exact same localisation pattern.  An interesting observation is that de-
phosphorylation of LaminA starts occurring upon binding of the Lamina to the chromatin 
(late anaphase).  In interphase, Lamin A/C phosphorylation was still present but at low 
levels, whereas in mitosis it was at high levels until cytokinesis, when the nuclear lamina is 
reformed.   
If Repo-Man is involved in de-phosphorylation of Lamin A, then it would be expected 
to observe a higher level of Lamin A/C S22ph also in interphase. Repo-Man RNAi treated 
cells were therefore analysed for Lamin A/C phosphorylation in interphase and were 
compared to the untreated cells at the same stage (Figure 4.3, A). Lamin A/C signal intensity 
was measured in a defined ROI covering the whole nucleus and these analyses indicated that 
in the absence of Repo-Man, there is increased Lamin A/C phosphorylation at interphase 
(Figure 4.3, C).  
These results indicate that Repo-Man directly or indirectly affects de-phosphorylation 
of Lamin A/C and the higher level of phosphorylated Lamin A/C could be responsible for the 
improper assembly of the NE observed after Repo-Man knock-down. Whether this is a result 
of a direct interaction between the proteins or an indirect consequence of Repo-Man activity 
is still unknown at this stage.  
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Furthermore, the normal level of Lamin A/C S22ph in interphase was restored when 
HeLa cells were transfected with oligo resistant wild type Repo-Man (Res2) in RNAi 
background; these cells showed less Lamin A/C phosphorylation in interphase than the un-
transfected cells, proving that presence of Repo-Man can rescue the normal levels of Lamin 
A/C phosphorylation (Figure 4.3, B and D). This clearly shows that the effect is indeed Repo-
Man dependent. 
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Figure 4.2: Phospho-Lamin A/C localisation throughout cell cycle. Lamin A/C 
phosphorylation (red) is high during mitosis (prophase-anaphase), it decreases after 
anaphase and goes back to the normal levels at cytokinesis, when the nuclear lamina is 
reformed (Scale bar 10µm). Images are representative of a single experiment. Fluorescent 
microscope is used. 
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Figure 4.3: Repo-Man knock-down causes increased phospho-Lamin A/C levels at 
interphase. A. HeLa cells transfected with control and Repo-Man siRNA and stained for 
Lamin A/C (phSer22). Increase levels of phospho-Lamin A/C were observed in the absence of 
Repo-Man at interphase (Scale bar 10µm). B. HeLa cells transfected with oligo-resistant wild 
type Repo-Man (Res2) in RNAi background (48h) and stained for phospho-Lamin A/C; 
phospho-Lamin A/C levels in interphase were rescued in Repo-Man transfected cells (Scale 
bar 10µm). C. Quantification of the experiment in A. Significant increase in phopsho-Lamin 
A/C levels with Repo-man RNAi. Mann-Whitney test is used for significance. D. 
Quantification of the experiment in B. Cells that lack Repo-Man (red arrows) have higher 
amount of phospho-Lamin A/C than the cells that are transfected with Repo-Man (white 
arrows). Mann-Whitney test is used for significance. Images are representative of three 
repeats. Total cell count is 30 for each experiment. Fluorescent microscope is used.   
ph 
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4.2.3 Sumoylation of Repo-Man is essential for Lamin A/C de-
phosphorylation. 
As mentioned before, SIM3 of Lamin A/C is important to facilitate the de-
phosphorylation of the Ser22 residue and re-incorporation of Lamin A/C to the nuclear 
envelope after mitosis. Live cell imaging and immunofluorescence experiments showed that 
SIM3 of Lamin A/C is required for Lamin A/C accumulation on chromosomes. In addition, 
mutation of SIM3 abolished de-phosphorylation of S22 residue of Lamin A/C (Moriuchi et al., 
2016).   Repo-Man is a chromatin associated phosphatase, active during mitotic exit whose 
depletion causes a persistance of hyperphosphorylated LaminA.  Moriuchi et al.,suggested 
that plusible candidates for the S22 de-phosphorylation could be BAF, emerin, and Repo-
Man. 
Repo-Man was reported as a SUMO 2/3 substrate in two different studies (Schou et 
al., 2014; Scimmel et al., 2014). We therefore analysed if Repo-Man could be sumoylated. 
Indeed K762 residue on Repo-Man is a plausible candidate for the SUMO2/3 modification, as 
shown in the GPS-SUMO database (An online database that predicts sumoylation sites) 
(Figure 4.4, A).   
The K762 residue was then mutated to Arginine (R) (Figure 4.4, B) and made oligo-
resistant (IRCE Res). HeLa cells were transfected with GFP:IRCE Res and wild type oligo-
resistant Repo-Man GFP:Res2 in RNAi background, to observe the localisation during mitosis. 
The IRCE mutant did not show any difference in localisation compared to the wild type 
during mitosis (Figure 4.4, C);  this shows that this mutant does not affect Repo-Man 
accumulation on chromosomes and both constructs expressed at a similar level, as assessed 
by wetsern blotting of HeLa transfected extracts  (Figure 4.4, D).  
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Figure 4.4: Repo-Man sumo mutant IRCE shows wild type-like localisation. A. Predicted 
sumoylation site on Repo-Man. B. Lys to Arg (K to R) mutation on Repo-Man K762. C. Oligo 
resistant Repo-Man wild type and IRCE mutant transfected HeLa cells in the presence of 
Repo-Man siRNA (48h) are shown at different stgaes of mitosis. IRCE mutant behaves exactly 
as the wild type protein in terms of localisation (Scale bar 10µm). D. Western blot showing 
the full length wild type and mutant Repo-Man, extracted from Repo-Man siRNA treated and 
Repo-Man wild type and IRCE (oligo resistant) transfected HeLa cells. Detected with anti-GFP 
antibody. α-Tubulin was used as loading control. Images are representative of a single 
experiment. Fluorescent microscope is used. 
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The sumo mutant was then used for a rescue experiment to test its effect on Lamin 
A/C de-phosphorylation.  HeLa cells were transfected with the wild type and mutant oligo-
resistant constructs in an RNAi background and the cells were analysed in interphase. The 
un-transfected cells in both, showed a high level of phospho-Lamin A/C as observed before 
and Repo-Man wild type transfected cells could rescue the phenotype (Figure 4.5, A Repo-
Man wt  1-3, 1’-3’). However, the sumo mutant transfected cells still had a certain amount of 
phospho-Lamin A/C present at interphase (Figure 4.5, A IRCE 1-3, 1’-3’), showing that the 
sumo mutant cannot rescue the phospho-Lamin A/C levels and therefore sumoylation of 
Repo-Man may have an effect on Lamin A/C de-phosphorylation.   
The IRCE mutant represents the non-sumoylated version of the protein and it cannot 
rescue the Lamin A/C phosphorylation back to the normal levels, suggesting that the wild 
type protein gets sumoylated and this has an effect on amin A/C S22ph levels. 
 We wanted to show that indeed Repo-Man can be sumoylated in vitro using  an in-
vitro sumoylation assay. GST tagged C terminal region (amino acids 391-1023) of wild type 
Repo-Man and sumo mutant (IRCE) were expressed in E.Coli Rosetta strain and the proteins 
were extracted by using Gluthatione agarose beads (Figure 4.6, A). The purified proteins 
were then used for the assay, to test if Repo-Man gets sumoylated and which SUMO protein 
is involved. For each sumo protein, reactions with and without ATP were prepared and the 
RanGAP1 protein, which is known to be modified by all three SUMO proteins, was used as a 
positive control. The results show a positive band for the control protein for each SUMO 
protein at 64kDa. However, neither wild type nor mutant Repo-Man had a positive band 
with any of the SUMO proteins (Figure 4.6, B). Overall, the sumoylation of Repo-Man was 
not detectable in-vitro, but I have strong evidence in favour of Repo-Man sumoylation.
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Figure 4.5: IRCE mutant cannot rescue phospho-LaminA/C levels at interphase. A. HeLa 
cells transfected with wild type and mutant oligo resistant Repo-Man and treated with Repo-
man siRNA (48h). Un-transfected cells (1,2,3 both panels) showing high levels of Lamin A/C 
phosphorylation, whereas wild type Repo-Man expression decreases these levels (1’, 2’, 3’ 
upper panel). The IRCE mutant however, cannot reverse the effect and rescue Lamin A/C 
phosphorylation levels (1’, 2’, 3’ lower panel) (Scale bar 10µm). B. There is significantly 
higher amount of phospho-Lamin A/C in IRCE transfected cells than Repo-Man wild type 
transfected cells (n=30). Total signal from transfected cells was normalised against the signal 
from the un-transfected cells.  Images are representative of three repeats. Total cell count is 
30 for each experiment. Fluorescent microscope is used. Mann-Whitney test is used for 
significance.    
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Figure 4.6: Repo-Man sumoylation cannot be detected in-vitro. A. GST tagged wild type and 
mutant Repo-Man extracted from E.Coli Rosetta strain by using Glutathione beads. Samples 
were run in duplicates for both proteins (1 and 2). B. Western blots showing the results for 
the in-vitro sumoylation assay. Sumoylation of wild type or mutant Repo-Man (RM and IRCE) 
could not be detected but sumoylation of RanGAP1 (RG1) was observed with all SUMO 
proteins. (+) indicates the positive reaction in the presence of ATP, whereas (-) indicates the 
negative reaction in the absence of ATP. RG1 sumoylation was observed at 64kDa.   
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4.2.4 Sumoylation of Repo-Man is important for the interaction with Lamin 
A/C 
Although sumoylation of Repo-Man could not be detected in-vitro, there was clear 
evidence of the effect of sumoylation Lamin A/C phosphorylation in the knock-down 
experiments. Further optimization was needed for the in-vitro sumoylation assay as the the 
control reactions worked for all SUMO proteins but amount of protein could have been 
insufficient for the other reactions to work. 
Due to the time constraints we could investigate this aspect further so we followed a 
different approach. Another system to investigate protein-protein interactions in vivo is the 
proximity ligation assay (PLA), which determines if two proteins are closer than 16nm. The 
assay makes use of primary antibodies of two different species that detects target proteins 
and secondary antibodies that have short sequences of oligonucleotides. The 
oligonucleotides ligate in close proximity and the signal is amplified with fluorescently 
labelled oligonucleotides.  
A PLA assay was conducted using a validated antibody against GFP (mouse) and the 
Lamin A/C S22ph antibody (rabbit) on HeLa cells. HeLa cells were transfected with GFP:Repo-
Manwt and GFP:Repo-ManIRCE in a Repo-Man RNAi background. Since the difference in 
phospho-Lamin A/C levels was detectable at interphase, we focused on the end of mitosis 
where we expected to see the interaction between Repo-Man and phospho-Lamin A/C. 
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Our results show that the interaction occurs in telophase and increases in interphase 
(Figure 4.7, A). The localisation of the interaction is not just confined to the nuclear lamina, 
but is spread all over the nucleus. Interestingly, the sumo mutant (IRCE) showed much less 
interactions with phospho-Lamin A/C then the wild type Repo-Man in interphase (Figure 4.7, 
A). However in telophase, the interaction between the mutant and phospho-Lamin A/C was 
not significantly different than that of wild type protein (Figure 4.7, B).  
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Figure 4.7: Repo-Man interacts with phospho-Lamin A/C at interphase and the sumo 
mutant IRCE decreases this interaction. A. HeLa cells transfected with oligo resistant wild 
type and mutant Repo-Man and with Repo-Man siRNA were blocked at with Nocadazole for 
3hrs and released for 2hrs before fixation to obtain high number of telophase cells. Each Cy3 
spot represents an interaction between the two proteins. The sumo mutant decreases the 
interaction both at interphase and telophase (Scale bar 10µm). B. Analysis of the 
experiment. Significant decrease with the sumo mutant was observed at interphase and not 
in telophase (n=50) (Chi-square test was used for significance) Images are representative of 
three repeats. Fluorescent microscope is used.  
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4.3 Discussion 
 Dis-assembly and re-assembly of the NE at mitosis depends,among other important 
factors,  on phosphorylation and de-phosphorylation of NE commponents including Nups 
and lamins. Repo-Man has already been shown to interact with some of these components 
like Importinβ (Vagnarelli et al., 2011; Qian et al., 2015). In addition, Repo-Man knockdown 
has an effect on the nuclear shape. However, the only proven NE-associated substrate for 
Repo-Man/PP1 complex so far reported is ImportinB. 
Here, guided by some recent discoveries on Lamin A/C de-phoshorylation, we have 
investigated the molecular mechanism that could be at the base of the occurrence of a mis-
shaped lamina following Repo-man depletion. 
Upon Repo-Man knock-down, the nuclei lost circularity as assessed by nuclear Lamin 
A/C staining. Furthermore, we rescued the abnormal lamina by using 75mM KCl and creating 
an hypotonic environment: this shows that the abnormal nuclear lamina can be reversed by 
an external force and that the phenotype observed is possibly caused by a weak NE that 
folds on itself thus producing the observed invaginations.  
Considering the phosphatase properties of Repo-Man/PP1, it would be plausible to 
infer that Repo-Man effect on Lamin A/C occurs through phosphorylation.  In particular, 
phosphorylation of Lamin A/C had been implicated in changes of its properties and linked to 
an increased mobility and a softer nucleus (Harada et al., 2014). To investigate if this was the 
case, we have used an antibody against Lamin A/C S22ph, as this is the most important 
mitotic phosphorylation on Lamin A/C and it has been related to chnages in Lamina mobility 
and assembly (Luscher et al., 1991; Harada et al., 2014).  
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Indeed, our studies showed that absence of Repo-Man affects de-phosphorylation of 
Lamin A/C at S22, and causes high levels of phosphorylated Lamin A/C to remain after 
mitosis. This phenotype is rescued and phospho-Lamin A/C levels decrease when Repo-Man 
is externally re-introduced. These data strongly support and unveil an important and new 
role for Repo-Man in controlling Lamin A/C de-phopshorylation.  
Another important aspect of this interaction is the mechanism. It was already shown 
that SIM3 of Lamin A/C promotes an interaction with a sumoylated protein that causes 
Lamin A/C de-phosphorylation at S22 (Moriuchi et al., 2016). This brought into question if  
Repo-Man could be acting directly on the Lamina. In order to do so, Repo-Man must be 
sumoylated. Previous report have identified Repo-man as sumoylated protein and have also 
identified a single sumoylation site within its the C-terminus domain.  Although the the 
SUMO mutant IRCE that we generated does not change the property of Repo-Man in terms 
of its localisation in the cells, it provides evidendence  that sumoylation of Repo-Man may be 
the mechanism behind this interaction. The IRCE mutant was generated by performing the 
common Lys to Arg (K to R) muatation, according to the data we gathered from previous 
studies on sumoylation of different proteins. This mutant, unlike the wild type, failed to 
rescue the Lamin A/C phosphorylation levels in interphase, suggesting that this mutation 
affects the interaction of Repo-Man with either Lamin A/C directly or with another 
phosphatase that then has Lamin A as a substrate. The PLA experiments seem to support the 
former hypothesis of a direct interaction between the two proteins, as the interaction 
decreases with the SUMO mutant both at telophase and interphase. Although we could not 
detect the in-vitro sumoylation of Repo-Man, we have several evidence that support this 
hypothesis including the PLA experiment and the rescue experiments with SUMO mutants.  
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Our working hypothesis is therefore the following: Repo-Man via its Sumoylated C-
teminus interacts directly with the SIM of LaminA and mediates the de-phosphorylation of 
the S22 during mitotic exit. Since Repo-Man persists in interphase as well and it is enriched 
at the nulcear periphery (De Castro et al, in press) and LaminA is phsophorylated also in 
interphase (Kochin et al., 2014) this could be a general mechanism that controls nuclear 
elasticity during several processes (Figure 4.8).  
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Figure 4.8: Working model. Lamin A/C phosphorylation by CDK1 at the beginning of mitosis 
promotes NE dis-assembly and at mitotic exit Repo-Man reverses this by de-phosphorylating 
Lamin A/C for its re-integration to the nuclear lamina. Our hypothesis is that Repo-Man 
accomplishes this by directly binding to the SIM of Lamin A/C after going through the 
sumoylation process itself. Sumoylation of Repo-Man promotes Lamin A/C binding and de-
phosphorylation is achieved. 
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 Repo-Man is up-regulated in several cancer types. Using an isogenic breast cancer 
model system (MCF10A and its derivatives), malignant (MCF10A-TK1) and metastatic 
(MCF10A-CA1h) breast cancer cells were compared to the normal cell line (MCF10A) for 
Repo-Man expression and it was shown that malignant and metastatic breast cancer 
tumours have high levels of Repo-Man (Vagnarelli, 2014). Furthermore, depletion of Repo-
Man stopped growth of malignant MCF10A-CA1h breast cancer cell line in soft agar (Peng et 
al., 2010), and arrested squamous cell carcinoma cells at G1, leading to apoptosis (Uchida et 
al., 2013).  
Repo-Man levels appear to be related to cancer progression in several ways. First, 
Repo-Man is known to be involved in DNA damage response (Peng et al., 2010), which can 
provide a platform for mutations and chromosome rearrangements. Second, Repo-Man 
controls chromosome segregation and counteracts Aurora B kinase, which may lead to 
aneuploidy and lagging chromosomes. Moreover, since Repo-Man is involved in de-
phosphorylating histone H3, its loss of function could cause problems in chromatin 
organization after mitosis and defects in heterochromatin environment and gene expression 
(DeCastro et al, 2016). 
In this chapter we focused on the effect of Repo-Man in breast cancer and, using the 
invasive MCF10A-CA1h and the triple negative HCC1143 cell lines as models, we tried to 
investigate the molecular mechanisms that link Repo-Man overexpression and cancer 
progression.
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Since we found that Repo-Man is highly overexpressed in triple negative breast 
cancers (TNBC), we focused on this type as it represents the most aggressive type of breast 
cancer with no current therapeutic targets. TBNC lacks oestrogen receptor (ER), 
progesterone receptor and Her2/neu. The absence of these markers makes TNBC not 
targetable or treatable and currently is the most aggressive type of breast cancer.  
Here we show that the high levels of Repo-Man occurs in different breast cancer cell 
lines when compared to the normal breast tissue; in addition, we monitor the wound healing 
capability of these cell lines using live cell imaging in the presence and absence of Repo-Man. 
We also report that Repo-Man expression levels affect the levels of important cancer 
markers like C-Myc and Aurora A.  Our results show that Repo-Man as an important cancer 
marker especially for triple negative breast cancer, which regulates malignancy through C-
Myc and Aurora A; most importantly, Repo-Man depletion halts the mobility of these breast 
cancer cells. 
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5.2 Results 
5.2.1 Repo-Man is overexpressed in triple negative breast cancer  
 The idea of Repo-Man being a cancer driver gene is a fairly new idea and there is not 
much research done on Repo-Man and cancer. The few studies that were published are 
mentioned above and these all suggest that overexpression of Repo-Man correlates with the 
aggressive behaviour of the tumour in certain types of cancers. Among these, the most 
striking study was from Peng et al., which reported that absence of Repo-Man causes breast 
cancer cells (MCF10A-CA1h and Tk1 cell lines) to stop growing on soft agar due to the cells 
being more susceptible to DNA damage. Taking this study as a starting point, we wanted to 
further investigate the effect of Repo-Man in different breast cancers and see if Repo-Man 
can be a therapeutic target for breast cancer.   
 We started our research by conducting a database search on Repo-Man expression 
levels in different grades of breast cancer. The data we obtained from the Oncomine 
database showed that as the grade gets higher, Repo-Man expression levels increase 
proportionally (Figure 5.1, A). Furthermore, there is a dramatic increase in Repo-Man 
expression in basal-like breast cancers, which includes the triple negative breast cancer, 
when compared to the normal breast tissue (Figure 5.1, B). Another important information 
we have come across during our database search was the survival curve of the lymph node 
positive patients. In patients that had low Repo-Man expression, the survival rate was 
significantly higher than the patients that had high Repo-Man expression (Figure 5.1, C). This 
clearly shows us the potential of Repo-Man as a diagnostic and prognostic marker. 
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Using UCSC cancer browser, we analysed Repo-Man expression (high seq dataset) in 
different types of breast cancers as well as the normal breast tissue. These include luminal A 
(ER+, PR+/-, HER2-) and luminal B (ER+, PR+/-, HER2+) types; basal, which include triple 
negative; and others which are ER and PR negative and HER2 positive. The data we obtained 
clearly shows that Repo-Man expression is higher in triple negative type of breast cancers 
(Figure 5.2, A).  
 Since these datasets are only available for mRNA levels, we wanted to analyse also 
the protein levels in different breast cancer cell lines. A comprehensive analysis of a wide 
range of breast cancer cell lines in terms of Repo-Man expression has already been done 
previously in our lab. The cell lines that were used and their properties are listed in table 5.1. 
Among these, here I only show the HCC1143 triple negative cell line and the MCF10A 
derivative CA1h cell line, because I have used these two cell lines for further experiments. 
We were able to detect high Repo-Man levels in all breast cancer cell lines including the 
triple negative cell lines HCC1143 and BT20 and the malignant CA1h. MCF10A and HMEC184 
(human mammary epithelial cells) have normal levels of Repo-Man and were used as 
controls, and tubulin staining was used as loading control (Figure 5.2, B). This western blot 
analysis showed high Repo-Man protein levels in these cancer cell lines. 
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     Table 5.1: List of cell lines used for western blot experiments to detect Repo-Man levels. 













BT474 Invasive ductal 
carcinoma 






BT20 Invasive ductal 
carcinoma  
Triple negative 
MCF7 Invasive ductal 
carcinoma  
ER, PR posıtıve 
  144 
 
Figure 5.1: Repo-Man is overexpressed in high grade aggressive breast cancer cell lines and 
decreases survival rates of breast cancer patients. A. Comparison of different grades of 
breast cancer in terms of Repo-Man expression (data obtained from Oncomine). Grade 1 
represents initial cancerous tissue, grade 2 represents malignancy and grade 3 represents 
metastatic behaviour. Repo-Man expression is highest in grade 3 breast cancers. B. Repo-
Man gene expression is high in basal-like (triple negative) breast cancers, when compared to 
normal breast tissue and non-basal like breast cancers (data obtained from Oncomine).  C. 
Survival rates of lymph node positive breast cancer patients with high or low Repo-Man 
expression. High Repo-Man levels cause low survival rates. 
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Figure 5.2: Repo-Man is overexpressed in triple negative breast cancer. A. Repo-Man 
expression levels in different types of breast cancer (UCSC cancer browser). Repo-Man 
expression is high in triple negative breast cancer (green boxes). B. Western blot showing 
Repo-Man levels in different breast cancer cell lines.  MCF10A and HMEC184 normal 
epithelial cells were used as controls. HCC1143 triple negative cell line and CA1h malignant 
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5.2.2 Repo-Man knock-down blocks wound healing ability in CA1h and 
HCC1143. 
 As mentioned before Repo-Man depletion has previously been reported to block the 
growth of malignant breast cancer cells on soft agar (Peng et al., 2010). Although the 
mechanism behind this was not clear, it was reported to be related with the interaction 
between Repo-Man and ATM kinase. Since Repo-Man negatively regulates the DNA damage 
response, its depletion causes a more efficient activation of the pathway and stops cell 
growth on soft agar (Peng et al, 2010).  
 We wanted to analyse how absence of Repo-Man would affect the growth and 
mobility of the two breast cancer cell lines we selected as a model (CA1h and HCC1143). For 
this purpose we depleted Repo-Man by RNA interference (control RNAi was used in parallel) 
and performed a wound healing assay. The wound was created after 24h of RNAi 
interference and the cells were observed for the next 24h by live cell imaging. Control cells 
were able to close the wound very efficiently within 20h however, the cells treated with 
Repo-Man siRNA could not close the wound in both cell lines within the same time frame 
(Figure 5.3, A and C).  
We have then asked the question “What is making the cells delay the wound closure 
in the absence of Repo-Man?”, and considered two possible answers: The first possibility is 
that cells stop dividing (effect on proliferation) and the second one that cells divide normally 
but move slower (effect on motility) in the absence of Repo-Man. 
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To address the two possibilities, I have conducted two different analyses:   the 
mitotic index and the velocity of the cell movement. I have first calculated the mitotic index 
of control and Repo-Man siRNA treated cells in both cell lines. For the mitotic index, cells 
were fixed at 20h after generating the wound and stained with H3T3ph (a marker for mitotic 
cells); H3T3ph positive cells were counted as well as the total cell number within 50µm 
radius around the wound at 3 different positions along the wound and the percentage of 
mitotic cells was calculated. The results show that there is no difference in the number of 
mitotic cells between control and siRNA treated cells as the mitotic index was the same in 
both conditions for both of the cell lines (Figure 5.3, E and F). This argues against the 
possibility of an inhibition of mitosis.  
I then calculated the velocity of cell movement. The calculations were conducted 
between time points 0 and 20h. The distance between the two edges of the wound was 
calculated every 30min between 0 and 20h and the velocity was calculated by dividing the 
difference in the distance by the time. Results showed a significant decrease in the velocity 
in Repo-Man depleted cells when compared to control cells (Figure 5.3 B and D). Moreover, 
it was observed that the triple negative cells were a lot slower than CA1h cells even without 
siRNA treatment.  
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All these results suggest that the absence of Repo-Man slows down the ability of 
migration both on the triple negative and CA1h breast cancer cells; taken our results 
together with the previous findings of a reduction of growth in soft agar, we can propose 
that Repo-Man can potentially be used as a therapeutic target for the treatment of breast 
cancer, including the triple negative. 
Now that we know the mechanism of action and relate high levels of Repo-Man with 
malignancy, we can look at other cancer markers and their relation with Repo-Man levels in 
the cell to see if we can control the levels of these markers through Repo-Man.   
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Figure 5.3: Repo-Man knockdown decreases CA1h and HCC1143 cells motility. A and C. 
Wound healing assay of CA1h and HCC1143 cells that are treated with control and Repo-
Man siRNA. This experiment was done by Lorena Ligammari. Repo-Man depleted cells 
cannot close the wound, whereas control cells efficiently do so. Scale bar 50µm. B and D. 
Velocities of CA1h and HCC1143 cell lines with control and Repo-Man siRNA treatments. 
There is a significant decrease in velocity for both cell lines when Repo-Man is depleted. E 
and F. Mitotic index of the wound healing assay for CA1h and HCC1143 cell lines 
respectively. The mitotic index is the same in control and Repo-Man siRNA treated cells in 
both cell lines. Images are representative of five repeats. Fluorescent microscope is used. 
Mann-Whitney test is used for significance.    
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5.2.3 Repo-Man knock-down decreases Aurora A levels in CA1h and 
HCC1143 cell lines 
 Since we have already established Repo-Man overexpression in triple negative breast 
cancer and results from our lab have shown that Repo-Man dosage contributes to the 
regulation of expression of Polycomb repressed genes (De Castro et al, 2016), we wanted to 
see how Repo-Man affects gene expression in breast cancer cells. A microarray analysis was 
performed in our lab and showed that, among the genes controlled by Repo-Man dosage, 
the expression of an inhibitor of Aurora A (AURKAIP1) was inversely proportional with Repo-
Man expression.  AURKAIP1 was previously reported to interact with Aurora A, leading to its 
ubiquitin-dependent degradation (Kiat et al., 2002; Lim and Gopalan, 2007) Therefore, Repo-
Man expression may indirectly affect Aurora A levels. 
 Aurora A has previously been reported to be involved in oncogenic pathways in 
several ways. By activating NK-ĸB transcription factor, Aurora A counteracts apoptosis and 
promotes cell survival (Sun C, et al., 2007). Similarly, by inhibiting the tumour suppressor 
gene p53, Aurora A blocks the intrinsic apoptotic pathway (Katayama, et al., 2004). Most 
importantly, Aurora A amplification is very common in breast cancers and by 
phosphorylating  the breast cancer gene BRCA1, Aurora A contributes to the silencing of the 
gene, causing the cells to proliferate (Ouchi M, et al., 2004).  
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We therefore decided to analyse the expression levels of Repo-Man, Aurora A and 
AURKAIP1 using the UCSC cancer browser database and found that AURKAIP1 expression is 
inversely proportional to Repo-Man levels, although the difference is not striking. However, 
we can argue that small differences in expression of a regulator could generate a much 
bigger downstream effect.  However, what was really impressive was the correlation 
between Repo-Man expression and Aurora A (Figure 5.4, A).  I have therefore investigated 
this relationship between Repo-Man and Aurora A with further immunostaining 
experiments. Repo-Man depleted and control CA1h and HCC1143 cells were stained with an 
Aurora A antibody and the signal intensity of Aurora A was calculated for both conditions.  
Aurora A is localised near the centrosome in late G1/early G2. With the progression 
of the cell cycle, Aurora A associates with the mitotic poles and the spindle. This association 
continues until through telophase until G1, when Aurora A gets degraded. Degradation of 
Aurora A is achieved in multiple ways. First way is through Cdh1 subunit of the APC (Crane et 
al., 2004); second is de-phosphorylation at Ser51 by PP2A (Horn et al., 2007); and third is by 
its interactor AURKAIP1 (Fumoto et al., 2008).   
Aurora A signal intensities at the two poles were measured in metaphase cells with a 
defined ROI and compared with the control cells. Unfortunately we were not able to detect 
Aurora A levels in triple negative breast cancer cells but with CA1h cells we observed a clear 
decrease in Aurora A levels when Repo-Man was depleted (Figure 5.4, B). With this 
experiment, we have shown that Repo-Man affects Aurora A also at protein level possibly via 
regulating its inhibitor AURKAIP1 expression; more interestingly these experiments show 
that we can control Aurora A levels via Repo-Man.  
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Figure 5.4: Repo-Man affects Aurora A levels through its inhibitor AURKAIP1. A. Expression 
levels of Repo-Man, Aurora A and AURKAIP1 in different breast cancers (UCSC cancer 
browser database). Orange areas are positive and blue areas are negative for the 
corresponding marker. Repo-Man overexpression in triple negative breast cancer 
corresponds with the low expression of AURKAIP1 and high expression of Aurora A. B. 
Control and Repo-Man siRNA treated CA1h cells were stained with Aurora A antibody. Both 
pro-metaphase and metaphase cells show low Aurora A levels. Scale bar 10µm. C. 
Quantification of the immunostaining experiment in B. Repo-Man siRNA treated cells have 
significantly lower levels of Aurora A. Mann-Whitney test is used. 30 cells counted in two 
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5.2.4 Repo-Man controls C-Myc levels in CA1h and HCC1143 cells 
 Being one of the most important transcription factors, C-Myc has already been 
established as an oncogene that controls growth regulation and cellular metabolism. 
Overexpression of C-Myc causes dramatic changes in gene expression levels, resulting in 
increased cell proliferation (Miller et al., 2012). Another member of the Myc family of 
proteins is the N-Myc, overexpression of which is observed mostly in neuroblastoma. 
 An important study showed that Aurora A serves as a stabilizer for N-Myc in 
neuroblastoma, preventing its degradation by ubiquitination. Otto et al., describe a pathway 
for N-Myc degradation (explained in Figure 5.5, A), where N-Myc is phosphorylated by GSK3 
at G1/S by CDK1/Cyclin B as well at G2/M. The second phosphorylation causes N-Myc to be 
degraded but this process is prevented by Aurora A binding (Otto et al., 2009).  
Since we have observed that we can control Aurora A levels in breast cancer cells 
through Repo-Man, and since N-Myc and C-Myc belong to the same family of proteins and 
they are structurally very similar, we wanted to find out if Repo-Man depletion also affects 
C-Myc levels. For this purpose, control and Repo-Man depleted CA1h and HCC1143 cells 
were stained for total C-Myc and the signal were measured in both cell lines. Our results 
show that when Repo-Man is depleted, C-Myc levels decrease significantly in both cell lines. 
This indicates that Repo-Man controls two of the most important oncogenes and especially 
for triple negative breast cancer this property of Repo-Man could represents a potential 
therapeutic target 
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Figure 5.5: Repo-Man controls C-Myc levels in malignant and triple negative breast cancer 
cells. A. Mechanism of action that explains how Aurora A prevents degradation of N-Myc in 
neuroblastoma (as described in Otto et al., 2009). B. Control and Repo-Man siRNA 
transfected CA1h and HCC1143 cells stained with C-Myc antibody, showing a decreased level 
of C-Myc in Repo-Man depleted cells for both cell lines. Scale bar 20µm. C and D. 
Quantification of the C-Myc staining of CA1h and HCC1143 respectively. C-Myc levels are 
significantly less in Repo-Man depleted cells. 30 cells counted in 10 different images.  
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5.3 Discussion 
 Although Repo-Man has not been defined as a cancer driver gene, it has been 
reported to be overexpressed in many cancers including synovial sarcoma, squamous cell 
carcinoma, neuroblastoma, lung cancer and breast cancer (Vagnarelli, 2014). In this chapter 
we focused on the role of Repo-Man/PP1 complex in breast cancer, specifically on the triple 
negative breast cancer, because we have shown increased levels of Repo-Man in this type of 
breast cancer. Another important reason to focus on breast cancer is the fact that Repo-Man 
depletion has been previously reported to stop the growth of malignant MCF10A-CA1h 
breast cancer cells on soft agar (Peng et al., 2010). Our aim was to understand the 
mechanism behind the effect of Repo-Man depletion and test Repo-Man as a therapeutic 
target for triple negative breast cancer. For this purpose, we have chosen MCF-10A-CA1h 
and HCC1143 cell lines as models, which represent malignant and triple negative breast 
cancer cells respectively.  
 Our starting point was to deplete Repo-Man and observe the behaviour of our model 
cell lines in a wound healing assay. Control and Repo-Man depleted cells were observed for 
24h with live cell imaging and the behaviour of both cell lines were analysed. The results 
were very striking in terms of cell movement. For both cell lines control cells did not have 
any difficulties closing the wounds but Repo-Man depleted cells could not close the wound. 
Here we show the results in the first 20 h because control cells efficiently close the wound 
within this time point and we took this time point as the reference as to how the cells should 
have behaved normally. In addition, both cell lines were moving visibly slow around the 
wound, not wanting to stretch or move across the wound; creating a heartbeat-like 
movement. Indeed, velocity analysis showed that Repo-Man depleted cells move 
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significantly slower than the control cells in both cell lines. Our first conclusion to explain 
Repo-Man mechanism of action is that it affects cell movement but we have also looked at 
the mitotic index to eliminate the possibility of Repo-Man affecting the ability of cells to 
divide.  
 Our studies on Repo-Man and breast cancer revealed another important role for 
Repo-Man: It affects the levels of two of the most important the important oncogenes, 
Aurora A and C-Myc. These two genes have already been shown as tumour inducing when 
overexpressed, as both of them affect important pathways that lead to apoptosis, cell 
proliferation and differentiation (Miller et al., 2012; Katayana H, et al., 2004). We have 
revealed this effect of Repo-Man by building on a previously performed microarray in our 
laboratory, which showed a decreased expression of an Aurora A inhibitor AURKAIP1 when 
Repo-Man was overexpressed. We have also analysed the expression profile on the UCSC 
database and furthermore, we have observed that Aurora A levels are directly proportional 
to Repo-Man levels. Indeed, our immunostaining experiments showed that Repo-Man 
depletion in breast cancer cells decreases Aurora A levels as well. Although we could not 
detect Aurora A levels in triple negative breast cancer, this was a particularly important 
result to explain how important Repo-Man is, in terms of driving malignancy in breast 
cancer. Moreover, it was shown that Aurora A prevents degradation of N-Myc in 
neuroblastoma (Otto et al., 2009) and the structural similarities between N-Myc and C-Myc 
made us wonder if the same prevention happens for C-Myc as well. With another 
immunostaining experiment we revealed that Repo-Man controls C-Myc levels and 
depending on the study that connects two proteins and our own results so far, we can 
hypothesize that this effect might happen through Aurora A. We have also conducted the
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 same immunostaining experiment with C-Myc in the presence and absence of an Aurora A 
inhibitor, however these experiments was inconclusive due to different results each time we 
repeated the experiment. This might have been due to the inhibitor that was used but the 
length of my PhD was not enough for me to test different inhibitors.  
 Nevertheless, our overall results on Repo-Man and breast cancer show that Repo-
Man has the potential to be used as a therapeutic target especially for triple negative breast 
cancer, as this type of breast cancer does not currently have reliable target molecules. Here 
we report a very significant and important role of Repo-Man in breast cancer: It controls the 
levels of important oncogenes, Aurora A and C-Myc, through an inhibitor of Aurora A and 
slows down the growth of cells in culture in its absence. These properties of Repo-Man 
certainly point out that it might be a cancer driving gene and, although we do not have 
further proof, Repo-Man may also control malignancy as well as metastasis.  
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6.1 Repo-Man binds to PP1 via a novel interaction motif: RepoSLIM 
With this project, we aimed to reveal how Repo-Man and PP1 bind to each other and 
identify regions within the molecules that can potentially be used to target and block the 
complex for the treatment of cancers where Repo-Man is overexpressed.  In this thesis, we 
also propose a novel regulatory mechanism for Repo-Man at mitosis. Furthermore, we 
explain the selective binding of Repo-Man to PP1γ and propose Repo-Man as a malignancy 
marker for triple negative breast cancer.  
Repo-Man, a multifunctional PP1 targeting subunit, is an important mitotic exit 
protein that regulates histone H3 de-phosphorylation at anaphase onset and is necessary for 
cell viability (Trinkle-Mulachy et al., 2006). The C terminal domain localizes Repo-Man to 
bulk chromatin in early anaphase to target PP1 for de-phosphorylation of histone H3 and the 
N terminal domain localizes Repo-Man to the chromosome periphery in late anaphase 
where it helps reassembly of the nuclear envelope by recruiting Importinβ and Nup153 in a 
PP1 independent manner (Vagnarelli et al., 2011).  
Repo-Man counteracts Haspin and Aurora B kinase by de-phosphorylating their 
targets on H3, which are Thr3 (Haspin), Ser10 and Ser28 (Aurora B) in a PP1 dependent 
manner (Qian et al., 2011; Dai and Higgins, 2005; Dai et al., 2006; Dai et al., 2005). Its 
absence was shown to leave H3 hyperphosphorylated, displace the CPC and, in turn, to 
cause lagging chromosomes (Qian et al., 2013; Qian et al., 2011; Vagnarelli et al., 2011; Qian 
et al., 2015).  
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Repo-Man was known to bind PP1 via the canonical RVTF motif, which is common to 
the majority of PP1 binding subunits (more than 200 identified) (Bollen et al., 2010). 
Therefore, the RVTF motif does not represent a useful interaction domain to target for 
therapeutical purposes. Mutation on the RVTF motif (the RAXA mutant), abolishes PP1 
binding completely and delays (but does not abolish) Repo-Man localisation on the mitotic 
chromatin (Trinkle-Mulachy et al., 2006), suggesting that there might be other important 
regulatory mechanisms. Indeed, the CDK1-Cyclin B phosphorylation sites T412 and T419 as 
well as S400 were shown to affect Repo-Man localisation on the chromatin, causing pre-
mature localisation at their phospho-deficient state (Vagnarelli et al., 2011, Qian et al., 
2015).  
To reveal the molecular basis for Repo-Man/PP1 complex, we collaborated with the 
Peti and Page laboratories (Brown University, USA) and identified the minimal binding region 
of Repo-Man/PP1 complex by NMR and crystallography (explained in detail in Kumar et al., 
2016). In addition to the previously identified points S400, T412 and T419, we have 
identified F404 and S407 as other potential regulatory sites on Repo-Man, according to their 
conformation when bound to PP1.  
These sites on Repo-Man are on the region flanking the RVTF motif that forms a 
hairpin-like structure on PP1 surface. They (apart from the F404) are not hidden on PP1 
surface, instead, they are exposed and they extend away from the PP1 surface. We have 
called this unique region the RepoSLIM (Small Linear Interacting Motif).  
  161 
The RepoSLIM is unique and not shared with any other PP1 binding subunits except 
for Ki67, which has been shown to be is the ancestor of Repo-Man (Booth et al., 2014). 
Indeed, the crystal structure of Ki67 bound to PP1 revealed that Ki67 and RepoSLIM matches 
perfectly in terms of the hairpin-like structure, with only a few small differences (explained 
in Kumar et al., 2016). We should emphasise here that the amino acid sequence of 
RepoSLIM is not shared with Ki67 but the similarity is caused by how the binding regions of 
both proteins align on PP1 surface. The differences on the other hand, are mostly angular, 
caused by the differences in the amino acid sequences. 
Overall, the RepoSLIM represents a unique interaction surface that could be a useful 
target for chemical disruption of protein-protein interaction (PPI). After the discovery of 
RepoSLIM, we have asked the question: Do the new sites on RepoSLIM have an effect on 
Repo-Man/PP1 complex formation and function, and also on Repo-Man localisation on 
chromatin. 
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6.2 Repo-Man is regulated by multiple kinases via the novel RepoSLIM   
Repo-Man has a characteristic localisation throughout the cell cycle. It changes from 
nuclear (interphase) to dispersed (Prometaphase/metaphase) and it localises on the mitotic 
chromatin at anaphase; this very dynamic localisation pattern is controlled by 
phosphorylations (Vagnarelli and Earnshaw, 2012). When Repo-Man is phosphorylated at 
mitotic entry, it loses its affinity for PP1 as well as to chromatin. As mitosis progresses, the 
phosphorylations are removed (by PP1 and PP2A) and Repo-Man localises on the 
chromosomes to de-phosphorylate histone H3 (Vagnarelli et al., 2011; Qian et al, 2011; Qian 
et al., 2015).  
It has been previously reported that CDK1-Cyclin B is responsible for phosphorylating 
Repo-Man at T412 and T419 and these phosphorylations affect Repo-Man affinity for 
chromosomes (Vaganrelli et al., 2011). The S400 residue was shown to have the exact same 
effect together with the CDK1 sites previously reported. Although S400 has been considered 
another CDK1 substrate (Qian et al., 2015), however there is no evidence provided to 
support CDK1 involvement for this phosphorylation (unlike the other 2 sites that were 
shown to be in vitro substrates of CDK1 (Vagnarelli et al, 2011). These data are nevertheless 
a strong indication of how Repo-Man regulations occur on the RepoSLIM. Furthermore, my 
mutation analyses on the RepoSLIM sites showed that the new sites are extremely important 
both for PP1 binding and Repo-Man localisation on chromosomes. This agrees with a recent 
analysis published by the Bollen laboratory (Qian et al, 2015). The S400, T412 and T419 and 
S400, S407, T412 and T419 combinations were mutated to Alanine and Aspartic Acid (3A and 
3D; 4A and 4D respectively). In addition, investigations of published databases suggested 
that S400 and S407 are predicted Plk1 phospho-sites, therefore these sites were mutated to 
  163 
Alanine only (2A) on their own. These two amino acid mutations are commonly used 
to mimic the phospho-deficient (Alanine) and phospho-mimetic (Aspartic Acid) states, 
because of their chemical confirmations.  
The 3A and 4A mutants had a strong premature localisation on chromosomes 
supporting the idea that these sites are clearly phosphorylated in vivo. The FA mutant on the 
other hand, behaved exactly like the wild type allele and did not fail to localise on the 
chromosomes in anaphase suggesting that the F404 does not play a major role in stabilising 
the interaction domain with PP1.  The differences in localisation between 3A/4A and 2A 
mutants show that phosphorylation of S400 and S407, the predicted Plk1 phosho-sites, on 
their own is not enough to block its localisation onto chromosomes and the CDK1 
phosphorylation is the pre-requisite for the full Repo-Man inactivation.  However, although 
the 2A mutant did behave like the wild type in terms of localisation, the total H3T3ph was 
much less than that of wild type suggesting that was still hyper-active. 
Interestingly, the localisation of the remaining H3T3ph with the 2A was entirely 
different than the wild type and no published mutant of Repo-Man has so far been reported 
to change this pattern. The normal localisation of H3T3ph is at the centromeres and the 2A 
mutant abolishes this localisation pattern. This result was further investigated in HeLa cells 
that stably express CENP-A, where I quantified the H3T3ph signal intensity at the CENP-A 
region and showed that the 2A mutant prevents the centromeric accumulation of H3T3ph. 
These data suggest that S400 and S407 phosphorylation contribute to maintain the H3T3ph 
at the centromeres. Moreover, the 2A mutant also showed that, when these sites cannot be 
phosphorylated, Repo-Man activity is higher but lacks localisation. We can therefore 
interpret that, whichever kinase is responsible for this phosphorylation, its activity is 
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somehow limited at the centromere during mitosis, hence we can observe a gradient of 
Repo-Man activity. Although we have not formally proven that the responsible kinase is Plk1, 
there is important evidence in favour of this hypothesis. First, active Plk1 is localised at 
centromeres during mitosis (Beck et al., 2013); second, Plk1 phosphorylates Haspin kinase 
and contributes towards its activation and promotes H3T3 phosphorylation (Zhou et al., 
2014). Therefore, as a kinase that regulates H3T3 phosphorylation, it would possibly be 
reasonable to postulate that it also blocks the removal of the exact same phosphorylation 
via inactivation of the responsible phosphatase: these mechanisms are very common in 
mitosis; third, Plk1 often acts by docking on previous phosphorylations on proteins, which 
are called priming sites, with its PBD (polo box domain) and CDK1 sites, especially at mitosis, 
serve as priming sites for Plk1 (Kishi et al., 2009). On Repo-Man, the CDK1 sites are the 
potential priming sites for Plk1 (as predicted on GPS-Polo), and S400 and S407 are identified 
as potential phospho-sites. Normally these priming and phospho-sites would be too far from 
each other but the hairpin-like binding of Repo-Man on PP1 surface brings these sites exactly 
opposite to each other, making it possible for Plk1 to function.  
In addition to CDK1 and putative Plk1 sites, our collaborators also identified T394 in 
the RVTF motif to be phosphorylated by Aurora B using in-vitro phosphorylation coupled to 
NMR spectroscopy and mass spectrometry (explained in Kumar et al., 2016). This finding is 
also very exiting since it shows that Repo-Man is potentially regulated by three mitotic 
kinases (CDK1, Plk1 and Aurora B) (Figure 6.1) on the RepoSLIM and that these 
phosphorylations contribute to prevent early Repo-Man localisation on chromosomes but 
also that are important for topological information.  
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In light of our data, we hypothesise that, since Aurora B and active Plk1 are 
centromeric kinases at mitosis, it is more likely that their activity forms a gradient on the 
chromosomes, which keeps Repo-Man really OFF at the centromeres. However, at the 
chromosome arms, the kinase activity is not present and Repo-Man can be active (still in a 
very dynamic status until anaphase onset). This gradient of kinase activity might be 
contributing to the generation of the localisation pattern of the remaining H3T3ph at the 
centromeres in mitosis.  
An alternative explanation for the mitotic H3T3ph pattern could be the CPC 
localisation per se. The CPC recognises and binds to H3T3ph via its subunit survivin (Kelly et 
al., 2010; Wang et al., 2010; Dai and Higgins, 2005). CPC binding to H3T3ph may physically 
block Repo-Man from removing this phosphorylation. And since Plk1 and CPC recruitment at 
the centromeres are dependent on each other (Zhou et al., 2014), these two mechanisms 
might be linked.  Further experiments are needed to identify the mechanism behind the 






















Figure 6.1: Overall schematic review of Repo-Man regulation along with Haspin and Aurora 
B kinases. In early mitosis phosphorylation of CDK1/Cyclin B targets have different effects on 
Repo-Man and Haspin. Recognition of the CDK1 phosphorylation on both proteins by Plk1 
causes further phosphorylation of both proteins. The phosphorylation has an activating 
effect on Haspin, and an inactivating effect on Repo-Man. Furthermore, phosphorylation of 
Repo-Man by Aurora B, keeps Repo-Man away from chromatin and CDK1 phosphorylation 
along with Plk1, prevents the binding of Repo-Man to PP1. After being activated by CDK1 
and Plk1, Haspin phosphorylates H3 at T3, which recruits CPC and a further phosphorylation 
by Aurora B enhances the T3 phosphorylation by Haspin. Recruitment of CPC also allows 
Aurora B to further phosphorylate T3 at S10 and S28. In late mitosis on the other hand, de-
phosphorylation of Repo-Man by both PP1 and PP2A activates the Repo-Man/PP1 complex, 
which then de-phosphorylates H3 at T3 along with S10 and S28. This causes the release of 
CPC from chromatin and allows chromosome segregation.   
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6.3 Repo-Man selectively binds to PP1γ  
Repo-Man localisation on the chromosomes is tightly regulated and it occurs in a 
timely manner exactly at anaphase onset. It is a dynamic event, depending on the activity of 
Repo-Man activating and inactivating proteins. We have already shown that the phospho-
sites on the RepoSLIM are important in facilitating Repo-Man localisation on chromosomes. 
In addition, Aurora B activity and PP2A-B56 binding has been reported to be important for 
the regulation of Repo-Man localization on chromosomes.  By phosphorylating Repo-Man at 
S893, Aurora B prevents premature localization until the phosphorylation is removed by 
PP2A-B56 and if Aurora B is inhibited, Repo-Man localizes on chromosomes at an early stage 
(Qian et al., 2011). Also a phospho-mimetic mutation on S893 abolishes Repo-Man 
localisation on chromosomes and causes H3T3 phosphorylation to remain (Qian et al., 2011; 
Qian et al., 2015). 
I have tested the contribution of these two mechanisms by using an inhibitor of 
Aurora B (ZM447439) on 3A and wild type Repo-Man transfected HeLa cells. The non PP1 
binding RAXA version of 3A and wild type Repo-Man were also used. The results confirmed 
that PP1 binding is important for Repo-Man localisation on chromosomes, as the RAXA 
version of both constructs (3A and wild type Repo-Man) abolished the pre-mature 
localisation in the absence of Aurora B inhibitor. However, in the presence of the Aurora B 
inhibitor, both 3A and wild type Repo-Man, as well as their RAXA versions, heavily localised 
on the chromosomes, suggesting that both mechanisms contribute to Repo-Man localisation 
on chromosomes.  
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The phospho-mimetic mutants of Repo-Man confirmed further that PP1 contribution 
is important for Repo-Man localisation on chromosomes. The 3D and 4D mutants behave 
like the wild type protein and do not show a pre-mature localisation on chromosomes. These 
mutants also cannot bind to PP1 in interphase, as shown with the Laci/LacO tethering 
experiments. Along with the Aurora B site T394, which also cannot bind to PP1, these 
mutants show that phospho-sites on RepoSLIM regulate PP1 binding.  
Despite the fact that PP1 isoforms have very little differences in their amino acid 
sequence, Repo-Man selectively binds to PP1γ and not any other PP1 isoform (Trinkle-
Mulcahy 2006). Most of these differences are at the C terminal region end and very few of 
them are at the N terminal region. Our collaborators have deleted the 15 amino acids that 
are different on PP1α and found that it does not affect PP1 binding (explained in Kunal et al., 
2016). However, they noticed that the R20 residue on PP1γ was in close proximity to Repo-
Man when the two proteins are bound to each other. This residue was also previously 
reported to effect PP1γ localisation throughout the cell cycle. I have therefore mutated this 
site in PP1γ and shown that this affects its localisation.  Moreover, using the Laci/LacO 
tethering system, I observed that Repo-Man binding to PP1γ was abolished completely in the 
R20Q mutant (to mimic the residue present in PP1 alpha).  The same is true also for Ki67 
showing that both these PP1 interacting proteins use the same binding mechanism to direct 
their specificity.  The same mutation on PP1γ abolished the binding of Ki67 as well. These 
findings confirm that Repo-Man selectively binds to PP1γ and a single amino acid change 
abolishes the binding and represent the first molecular demonstration of isoform specificity 
for PP1 targeting subunits. 
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6.4 Lamin A/C is a substrate of Repo-Man at interphase  
  Although the S22 phosphorylation on Lamin A/C is mostly known as a mitotic marker 
that favours nuclear lamina disassembly (Heald and McKeen, 1990), recent studies have 
shown that it also gets phosphorylated in interphase (Kochin et al., 2014). Furthermore, de-
phopshorylation of S22 of Lamin A/C has been shown to be dependent on its SIM3 (Moriuchi 
et al., 2016).  
 Repo-Man has been shown to interact with nuclear envelope (NE) proteins like 
Nup153 and Importinβ and help nuclear envelope reassembly (Vagnarelli et al., 2011). It was 
also shown that Repo-Man knockdown causes abnormal NE. 
 Here we have shown that Repo-Man depletion causes increased Lamin A/C 
phosphorylation at S22 in interphase and that we can rescue this phenotype by transfecting 
the cells with the oligo resistant wild type Repo-Man in RNAi background. This clearly shows 
that Repo-Man somehow affects Lamin A/Cph levels in interphase but the mechanism is not 
yet clear.  
 Since we know that de-phsophorylation of S22 is SIM3 mediated, we wanted to know 
if Repo-Man effect on Lamin A/C de-phosphorylation is through Repo-Man sumoylation. The 
proposed SUMO-site on Repo-Man (K762) (Schou et al., 2014, GPS-SUMO) was mutated to R 
(IRCE) and the behaviour of the mutant was observed in terms of localisation and Lamin A/C 
de-phosphorylation in RNAi background. The IRCE did not behave any different than the wild 
type in terms of localisation, suggesting that this region at the C terminal tail of Repo-Man is 
not responsible for localisation and the mutant can be expressed in full length. However, the 
IRCE could not rescue the S22ph levels at interphase, showing that sumoylation may indeed 
be the mechanism of how the two proteins interact. Although we could not detect 
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sumoylation of Repo-Man in-vitro, there is solid evidence that Repo-Man sumoylation 
mediates de-phosphorylation of Lamin A/C. the fact that IRCE mutant could not rescue the 
phenotype is a strong argument in favour of this mechanism. In addition, the interaction of 
two proteins, which was detected by PLA, is much less with the IRCE mutant at interphase. 
Since S22 phosphorylation also happens in interphase, this interaction could potentially 
meant that Repo-Man de-phosphorylates the pool of Lamin A/C that gets phosphorylated at 
interphase, or this interaction could be the result of the timely integration of the nuclear 
lamina proteins to the NE. Therefore, Lamin A/C integration might be later than other 
proteins like Importin β, hence the de-phosphorylation continues at interphase.  
 Although we are still not clear about the exact mechanism, we have shown that 
Lamin A/C is a potential substrate of Repo-Man/PP1 complex. This fits perfectly well within 
the role of the complex at mitotic exit, as it is an established regulator of both chromatin 
environment and NE reassembly.  
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6.5 Repo-Man could represent a therapeutic target for the treatment of triple 
negative breast cancer    
Repo-Man has been shown to be overexpressed in many cancers including 
neuroblastoma (Krasnoselsky et al., 2005), melanoma (Ryu et al., 2007), synovial sarcoma 
(Wozniak et al., 2013), squamous cell carcinoma (Uchida et al., 2013) and breast cancer 
(Peng et al., 2010). Furthermore, its depletion was shown to stop the growth of malignant 
breast cancer cells on soft agar, and induce apoptosis of squamous cell carcinoma cells. 
These studies also revealed that high level of Repo-Man is correlated with poor prognosis 
and metastatic tumours. 
Here we used the malignant CA1h and the triple negative HCC1143 cell lines as 
models to show Repo-Man overexpression and the effect of its depletion. Using a wound-
healing assay, we have shown that, in the absence of Repo-Man, the two cell lines had 
impaired movement. Which indicates that Repo-Man depletion could potentially inhibit or 
delay metastasis.  
Moreover, Repo-Man depletion caused a decreased protein level of Aurora A and C-
Myc and this could represent and interesting signalling cascade. Aurora A was shown to act 
as a stabilizer for N-Myc, preventing its degradation (Otto et al., 2009) and since C and N-
Myc have structural similarities, this role could be expected for c-myc as well although it has 
never been demonstrated. Here we have observed the same effect in our model cell lines.  
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According to a microarray experiment conducted in the lab upon Repo-Man 
depletion on the Ca1H cell line, Repo-Man knock down causes up-regulation of AURKAP1 
gene expression. AURKAP1 has been proposed to regulate Aurora A degradation (Fumoto et 
al., 2008).   
These findings are quite important in terms of treatment for especially the triple 
negative breast cancer, as it does not express any of the markers that are currently used to 
treat breast cancer (ER, PR, Her2). We hypothesise that targeting the RepoSLIM and 
abolishing the Repo-Man PP1 binding through a peptide specifically designed to compete 
with Repo-Man for PP1 binding, could decrease the malignant and metastatic properties of 
triple negative breast cancers (Figure 6.2). When used in combination with other drugs, this 
could serve as an effective treatment.  
Up to date, no chemical or peptide has been reported to block the binding of Repo-
Man/PP1 complex except for one (Chatterjee et al., 2012) but we could not see the reported 
results with this peptide as it was designed to block the RVTF motif and was not specific to 
Repo-Man. Clearly a more specific approach must be undertaken to identify small molecules 
that can target the RepoSLIM. A possible approach could be the split-intein circular ligation 
of peptides and proteins (SICLOPPS), which releases a linear product and a circularized 
peptide and can be manipulated to express a target protein inside the cell (Gohard et al., 
2014; Tavassoli and Benkovic, 2007). This would eliminate the cellular intake problems but a 
more specific targeting is needed.  
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Figure 6.2: The overall working model. Targeting Repo-Man through the RepoSLIM in Repo-
Man overexpressed triple negative breast cancer cells would potentially decrease Aurora A 
levels through the Aurora A inhibitor AURKAP1, causing C-Myc degradation.  
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